Products OverviewCompany pmod.com Site Map
Home News Contact Us
Kinetic Modeling | Image Fusion | Image Viewing Troubleshooting | FAQ | Documentation | Download Users | Partnership | History | People News Contact Us Ordering
[Support > Publications]
450 selected Publications using PMOD for their Data Analysis
2012
  1. Michaelides M, Thanos PK, Kim R, Cho J, Ananth M, Wang G-J, Volkow ND. PET imaging predicts future body weight and cocaine preference. Neuroimage. 2012;59(2):1508-1513.
  2. Odano I, Varrone A, Savic I, Ciumas C, Karlsson P, Jucaite A, Halldin C, Farde L. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter - Application to juvenile myoclonic epilepsy. Neuroimage. 2012;59(4):3582-3593.
  3. Yashio K, Katayama Y, Takashima T, Ishiguro N, Doi H, Suzuki M, Wada Y, Tamai I, Watanabe Y. Synthesis of [11C]uric acid, using [11C]phosgene, as a possible biomarker in PET imaging for diagnosis of gout. Bioorganic & Medicinal Chemistry Letters. 2012;22(1):115-119.
2011
  1. Barthel H, Gertz H-J, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C, Sabri O. Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. The Lancet Neurology. 2011;10(5):424-435.
  2. Barthel H, Luthardt J, Becker G, Patt M, Hammerstein E, Hartwig K, Eggers B, Sattler B, Schildan A, Hesse S, Meyer PM, Wolf H, Zimmermann T, Reischl J, Rohde B, Gertz HJ, Reininger C, Sabri O. Individualized quantification of brain beta-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging. 2011;38(9):1702-14.
  3. Bouquet W, Deleye S, Staelens S, De Smet L, Van Damme N, Debergh I, Ceelen WP, De Vos F, Remon JP, Vervaet C. Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model. Pharm Res. 2011;28(7):1653-60.
  4. Chauveau F, Boutin H, Van Camp N, Thominiaux C, Hantraye P, Rivron L, Marguet F, Castel MN, Rooney T, Benavides J, Dolle F, Tavitian B. In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa). Eur J Nucl Med Mol Imaging. 2011;38(3):509-14.
  5. Chen PS, Yeh TL, Lee IH, Lin CB, Tsai HC, Chen KC, Chiu N-T, Yao WJ, Yang YK, Chou Y-H. Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers -- A SPECT study. Neuroimage. 2011;In Press, Corrected Proof.
  6. Deuther-Conrad W, Fischer S, Hiller A, Becker G, Cumming P, Xiong G, Funke U, Sabri O, Peters D, Brust P. Assessment of alpha7 nicotinic acetylcholine receptor availability in juvenile pig brain with [(1)F]NS10743. Eur J Nucl Med Mol Imaging. 2011;38(8):1541-9.
  7. Dickstein LP, Zoghbi SS, Fujimura Y, Imaizumi M, Zhang Y, Pike VW, Innis RB, Fujita M. Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography. Eur J Nucl Med Mol Imaging. 2011;38(2):352-7.
  8. Ettrup A, Hansen M, Santini MA, Paine J, Gillings N, Palner M, Lehel S, Herth MM, Madsen J, Kristensen J, Begtrup M, Knudsen GM. Radiosynthesis and in vivo evaluation of a series of substituted (11)C-phenethylamines as 5-HT (2A) agonist PET tracers. Eur J Nucl Med Mol Imaging. 2011;38(4):681-93.
  9. Ettrup A, Mikkelsen JD, Lehel S, Madsen J, Nielsen EÃ, Palner M, Timmermann DB, Peters D, Knudsen GM. 11C-NS14492 as a Novel PET Radioligand for Imaging Cerebral α7 Nicotinic Acetylcholine Receptors: In Vivo Evaluation and Drug Occupancy Measurements. Journal of Nuclear Medicine. 2011;52(9):1449-1456.
  10. Finnema SJ, Varrone A, Hwang TJ, Halldin C, Farde L. Confirmation of fenfluramine effect on 5-HT(1B) receptor binding of [(11)C]AZ10419369 using an equilibrium approach. J Cereb Blood Flow Metab. 2011.
  11. Fischer K, Sossi V, Schmid A, Thunemann M, Maier FC, Judenhofer MS, Mannheim JG, Reischl G, Pichler BJ. Noninvasive nuclear imaging enables the in vivo quantification of striatal dopamine receptor expression and raclopride affinity in mice. J Nucl Med. 2011;52(7):1133-41.
  12. Garcia A, Mirbolooki MR, Constantinescu C, Pan M-L, Sevrioukov E, Milne N, Wang PH, Lakey J, Chandy KG, Mukherjee J. 18F-Fallypride PET of Pancreatic Islets: In Vitro and In Vivo Rodent Studies. Journal of Nuclear Medicine. 2011;52(7):1125-1132.
  13. Gould RW, Gage HD, Banks ML, Blaylock BL, Czoty PW, Nader MA. Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys. Neuropharmacology. 2011;61(1-2):245-251.
  14. Guenther T, Schönknecht P, Becker G, Olbrich S, Sander C, Hesse S, Meyer PM, Luthardt J, Hegerl U, Sabri O. Impact of EEG-vigilance on brain glucose uptake measured with [18F]FDG and PET in patients with depressive episode or mild cognitive impairment. Neuroimage. 2011;56(1):93-101.
  15. Haerle SK, Fischer DR, Schmid DT, Ahmad N, Huber GF, Buck A. 18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT. Mol Imaging Biol. 2011;13(5):1036-42.
  16. Hanin Fo-X, Pauwels S, Bol A, Melis M, Breeman W, de Jong M, Jamar Fo. Effect of Interferon-α Treatment on [68Ga-DOTA,Tyr3,Thre8]Octreotide Uptake in CA20948 Tumors: A Small-Animal PET Study. Journal of Nuclear Medicine. 2011;52(4):580-585.
  17. Herholz K, Westwood S, Haense C, Dunn G. Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment. Journal of Nuclear Medicine. 2011;52(8):1218-1226.
  18. Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA, Innis RB. Reversible and regionally selective downregulation of brain cannabinoid CB(1) receptors in chronic daily cannabis smokers. Mol Psychiatry. 2011.
  19. Hoekzema E, Rojas S, Herance Rl, Pareto D, Abad S, Jimenez X, Figueiras FP, Popota F, Ruiz A, Flotats Nr, Fernandez FJ, Rocha M, Rovira M, Victor VcM, Gispert JD. [11C]-DASB microPET imaging in the aged rat: Frontal and meso-thalamic increases in serotonin transporter binding. Experimental Gerontology. 2011;46(12):1020-1025.
  20. Huang CL, Wu YW, Wang SS, Tseng CD, Chiang FT, Hsu KL, Lee CM, Tzen KY. Continuous intravenous infusion of prostaglandin E1 improves myocardial perfusion reserve in patients with ischemic heart disease assessed by positron emission tomography: a pilot study. Ann Nucl Med. 2011;25(7):462-8.
  21. Kambe T, Motoi Y, Inoue R, Kojima N, Tada N, Kimura T, Sahara N, Yamashita S, Mizoroki T, Takashima A, Shimada K, Ishiguro K, Mizuma H, Onoe H, Mizuno Y, Hattori N. Differential regional distribution of phosphorylated tau and synapse loss in the nucleus accumbens in tauopathy model mice. Neurobiology of Disease. 2011;42(3):404-414.
  22. Kemerink GJ, Visser MG, Franssen R, Beijer E, Zamburlini M, Halders SG, Brans B, Mottaghy FM, Teule GJ. Effect of the positron range of 18F, 68Ga and 124I on PET/CT in lung-equivalent materials. Eur J Nucl Med Mol Imaging. 2011;38(5):940-8.
  23. Kendziorra K, Wolf H, Meyer PM, Barthel H, Hesse S, Becker GA, Luthardt J, Schildan A, Patt M, Sorger D, Seese A, Gertz HJ, Sabri O. Decreased cerebral alpha4beta2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging. 2011;38(3):515-25.
  24. Kimura Y, Fujita M, Hong J, Lohith TG, Gladding RL, Zoghbi SS, Tauscher JA, Goebl N, Rash KS, Chen Z, Pedregal C, Barth VN, Pike VW, Innis RB. Brain and Whole-Body Imaging in Rhesus Monkeys of 11C-NOP-1A, a Promising PET Radioligand for Nociceptin/Orphanin FQ Peptide Receptors. Journal of Nuclear Medicine. 2011;52(10):1638-1645.
  25. Kupers R, Frokjaer VG, Erritzoe D, Naert A, Budtz-Joergensen E, Nielsen FA, Kehlet H, Knudsen GM. Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: A [11C]DASB PET study. Neuroimage. 2011;54(2):1336-1343.
  26. Kurland BF, Peterson LM, Lee JH, Linden HM, Schubert EK, Dunnwald LK, Link JM, Krohn KA, Mankoff DA. Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by 18F-Fluoroestradiol PET. Journal of Nuclear Medicine. 2011;52(10):1541-1549.
  27. la Fougere C, Grant S, Kostikov A, Schirrmacher R, Gravel P, Schipper HM, Reader A, Evans A, Thiel A. Where in-vivo imaging meets cytoarchitectonics: The relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET. Neuroimage. 2011;56(3):951-960.
  28. la Fougère C, Grant S, Kostikov A, Schirrmacher R, Gravel P, Schipper HM, Reader A, Evans A, Thiel A. Where in-vivo imaging meets cytoarchitectonics: The relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET. Neuroimage. 2011;56(3):951-960.
  29. Lambert B, Sturm E, Mertens J, Oltenfreiter R, Smeets P, Troisi R, Van Vlierberghe H, Defreyne L. Intra-arterial treatment with (90)Y microspheres for hepatocellular carcinoma: 4 years experience at the Ghent University Hospital. Eur J Nucl Med Mol Imaging. 2011;38(12):2117-24.
  30. Lin K-J, Lin W-Y, Hsieh C-J, Weng Y-H, Wey S-P, Lu C-S, Skovronsky D, Yen T-C, Chang C-J, Kung M-P, Hsiao I-T. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements. Nuclear Medicine and Biology. 2011;38(8):1149-1155.
  31. Lu P-L, Chen Y-C, Ou T-W, Chen H-H, Tsai H-C, Wen C-J, Lo C-L, Wey S-P, Lin K-J, Yen T-C, Hsiue G-H. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Biomaterials. 2011;32(8):2213-2221.
  32. Luquin MR, Manrique M, Guillan J, Arbizu J, Ordonez C, Marcilla I. Enhanced GDNF expression in dopaminergic cells of monkeys grafted with carotid body cell aggregates. Brain Research. 2011;1375(0):120-127.
  33. Madsen K, Erritzoe D, Mortensen EL, Gade A, Madsen J, Baare W, Knudsen GM, Hasselbalch SG. Cognitive function is related to fronto-striatal serotonin transporter levels--a brain PET study in young healthy subjects. Psychopharmacology (Berl). 2011;213(2-3):573-81.
  34. Madsen K, Haahr MT, Marner L, Keller SH, Baare WF, Svarer C, Hasselbalch SG, Knudsen GM. Age and sex effects on 5-HT(4) receptors in the human brain: a [(11)C]SB207145 PET study. J Cereb Blood Flow Metab. 2011.
  35. Madsen K, Marner L, Haahr M, Gillings N, Knudsen GM. Mass dose effects and in vivo affinity in brain PET receptor studies - a study of cerebral 5-HT4 receptor binding with [11C]SB207145. Nuclear Medicine and Biology. 2011;38(8):1085-1091.
  36. Madsen K, Neumann WJ, Holst K, Marner L, Haahr MT, Lehel S, Knudsen GM, Hasselbalch SG. Cerebral serotonin 4 receptors and amyloid-beta in early Alzheimer's disease. J Alzheimers Dis. 2011;26(3):457-66.
  37. Maftei C-A, Shi K, Bayer C, Astner ST, Vaupel P. Comparison of (immuno-)fluorescence data with serial [18F]Fmiso PET/CT imaging for assessment of chronic and acute hypoxia in head and neck cancers. Radiotherapy and Oncology. 2011;99(3):412-417.
  38. Mancuso M, Orsucci D, Volterrani D, Siciliano G. Cognitive impairment and McArdle disease: Is there a link? Neuromuscular Disorders. 2011;21(5):356-358.
  39. Marner L, Knudsen GM, Madsen K, Holm S, Baare W, Hasselbalch SG. The reduction of baseline serotonin 2A receptors in mild cognitive impairment is stable at two-year follow-up. J Alzheimers Dis. 2011;23(3):453-9.
  40. Meyer PT, Hellwig S, Amtage F, Rottenburger C, Sahm U, Reuland P, Weber WA, Hall M. Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B. Journal of Nuclear Medicine. 2011;52(3):393-400.
  41. Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, Byrne F, Prina-Mello A, Volkov Y, Li S, Mather SJ, Bianco A, Prato M, MacNee W, Wallace WA, Kostarelos K, Donaldson K. Length-Dependent Retention of Carbon Nanotubes in the Pleural Space of Mice Initiates Sustained Inflammation and Progressive Fibrosis on the Parietal Pleura. The American Journal of Pathology. 2011;178(6):2587-2600.
  42. Nguyen H-N, Wey S-P, Juang J-H, Sonaje K, Ho Y-C, Chuang E-Y, Hsu C-W, Yen T-C, Lin K-J, Sung H-W. The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo. Biomaterials. 2011;32(10):2673-2682.
  43. Nkoulou R, Pazhenkottil AP, Kuest SM, Ghadri JR, Wolfrum M, Husmann L, Fiechter M, Buechel RR, Herzog BA, Koepfli P, Burger C, Gaemperli O, Kaufmann PA. Semiconductor Detectors Allow Low-Dose - Low-Dose 1-Day SPECT Myocardial Perfusion Imaging. Journal of Nuclear Medicine. 2011;52(8):1204-1209.
  44. Oh U, Fujita M, Ikonomidou VN, Evangelou IE, Matsuura E, Harberts E, Fujimura Y, Richert ND, Ohayon J, Pike VW, Zhang Y, Zoghbi SS, Innis RB, Jacobson S. Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol. 2011;6(3):354-61.
  45. Penheiter AR, Griesmann GE, Federspiel MJ, Dingli D, Russell SJ, Carlson SK. Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors. Gene Ther. 2011.
  46. Rojas S, Martin A, Pareto D, Herance JR, Abad S, Ruiz A, Flotats N, Gispert JD, Llop J, Gomez-Vallejo V, Planas AM. Positron emission tomography with 11C-flumazenil in the rat shows preservation of binding sites during the acute phase after 2h-transient focal ischemia. Neuroscience. 2011;182(0):208-216.
  47. Rusjan PM, Wilson AA, Bloomfield PM, Vitcu I, Meyer JH, Houle S, Mizrahi R. Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography. J Cereb Blood Flow Metab. 2011;31(8):1807-16.
  48. Shukuri M, Takashima-Hirano M, Tokuda K, Takashima T, Matsumura K, Inoue O, Doi H, Suzuki M, Watanabe Y, Onoe H. In Vivo Expression of Cyclooxygenase-1 in Activated Microglia and Macrophages During Neuroinflammation Visualized by PET with 11C-Ketoprofen Methyl Ester. Journal of Nuclear Medicine. 2011;52(7):1094-1101.
  49. Sobrado M, Delgado M, Fernández-Valle E, Garcia-Garcia L, Torres M, Sanchez-Prieto J, Vivancos J, Manzanares R, Moro MA, Pozo MA, Lizasoain I. Longitudinal studies of ischemic penumbra by using 18F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats. Neuroimage. 2011;57(1):45-54.
  50. Sonaje K, Lin K-J, Tseng MT, Wey S-P, Su F-Y, Chuang E-Y, Hsu C-W, Chen C-T, Sung H-W. Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins. Biomaterials. 2011;32(33):8712-8721.
  51. Spreckelmeyer KN, Paulzen M, Raptis M, Baltus T, Schaffrath S, Van Waesberghe J, Zalewski MM, Risch F, Vernaleken I, Schäfer WM, Gründer G. Opiate-Induced Dopamine Release Is Modulated by Severity of Alcohol Dependence: An [18F]Fallypride Positron Emission Tomography Study. Biological Psychiatry. 2011;70(8):770-776.
  52. Stahl AR, Heusner TA, Hartung V, Nagarajah J, Bockisch A, Hahn S, Antoch G, Jentzen W. Time Course of Tumor SUV in 18F-FDG PET of Breast Cancer: Presentation of a Simple Model Using a Single Reference Point for Time Corrections of Tumor SUVs. Journal of Nuclear Medicine. 2011;52(1):18-23.
  53. Strauss LG, Pan L, Cheng C, Haberkorn U, Dimitrakopoulou-Strauss A. Shortened acquisition protocols for the quantitative assessment of the 2-tissue-compartment model using dynamic PET/CT 18F-FDG studies. J Nucl Med. 2011;52(3):379-85.
  54. Stuart CA, Ross IR, Howell MEA, McCurry MP, Wood TG, Ceci JD, Kennel SJ, Wall J. Brain glucose transporter (Glut3) haploinsufficiency does not impair mouse brain glucose uptake. Brain Research. 2011;1384:15-22.
  55. Takahashi K, Yamagishi G, Hiramatsu T, Hosoya A, Onoe K, Doi H, Nagata H, Wada Y, Onoe H, Watanabe Y, Hosoya T. Practical synthesis of precursor of [N-methyl-11C]vorozole, an efficient PET tracer targeting aromatase in the brain. Bioorganic & Medicinal Chemistry. 2011;19(4):1464-1470.
  56. Takashima T, Yokoyama C, Mizuma H, Yamanaka H, Wada Y, Onoe K, Nagata H, Tazawa S, Doi H, Takahashi K, Morita M, Kanai M, Shibasaki M, Kusuhara H, Sugiyama Y, Onoe H, Watanabe Y. Developmental Changes in P-Glycoprotein Function in the Blood-Brain Barrier of Nonhuman Primates: PET Study with R-11C-Verapamil and 11C-Oseltamivir. Journal of Nuclear Medicine. 2011;52(6):950-957.
  57. Takashima-Hirano M, Takashima T, Katayama Y, Wada Y, Sugiyama Y, Watanabe Y, Doi H, Suzuki M. Efficient sequential synthesis of PET Probes of the COX-2 inhibitor [11C]celecoxib and its major metabolite [11C]SC-62807 and in vivo PET evaluation. Bioorganic & Medicinal Chemistry. 2011;19(9):2997-3004.
  58. Tseng J-H, Ouyang C-H, Lin K-J, Yeh T-S. Significance of Insulin Signaling in Liver Regeneration Triggered by Portal Vein Ligation. Journal of Surgical Research. 2011;166(1):77-86.
  59. Tsukada H, Ohba H, Nishiyama S, Kakiuchi T. Differential effects of stress on [(1)(1)C]raclopride and [(1)(1)C]MNPA binding to striatal D/D dopamine receptors: a PET study in conscious monkeys. Synapse. 2011;65(1):84-9.
  60. van Rij CM, Sharkey RM, Goldenberg DM, Frielink C, Molkenboer JDM, Franssen GM, van Weerden WM, Oyen WJG, Boerman OC. Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody. Journal of Nuclear Medicine. 2011;52(10):1601-1607.
  61. Vandeputte C, Evens N, Toelen J, Deroose CM, Bosier B, Ibrahimi A, Van der Perren A, Gijsbers R, Janssen P, Lambert DM, Verbruggen A, Debyser Z, Bormans G, Baekelandt V, Van Laere K. A PET Brain Reporter Gene System Based on Type 2 Cannabinoid Receptors. Journal of Nuclear Medicine. 2011;52(7):1102-1109.
  62. Vangestel C, Van de Wiele C, Van Damme N, Staelens S, Pauwels P, Reutelingsperger CPM, Peeters M. 99mTc-(CO)3 His-Annexin A5 Micro-SPECT Demonstrates Increased Cell Death by Irinotecan During the Vascular Normalization Window Caused by Bevacizumab. Journal of Nuclear Medicine. 2011;52(11):1786-1794.
  63. Varnas K, Nyberg S, Halldin C, Varrone A, Takano A, Karlsson P, Andersson J, McCarthy D, Smith M, Pierson ME, Soderstrom J, Farde L. Quantitative analysis of [(11)C]AZ10419369 binding to 5-HT(1B) receptors in human brain. J Cereb Blood Flow Metab. 2011;31(1):113-23.
  64. Varrone A, Stepanov V, Nakao R, Tóth Ms, Gulyás Bz, Emond P, Deloye JB, Vercouillie J, Stabin MG, Jonsson C, Guilloteau D, Halldin C. Imaging of the Striatal and Extrastriatal Dopamine Transporter with 18F-LBT-999: Quantification, Biodistribution, and Radiation Dosimetry in Nonhuman Primates. Journal of Nuclear Medicine. 2011;52(8):1313-1321.
  65. Varrone A, Toth Ms, Steiger C, Takano A, Guilloteau D, Ichise M, Gulyas Bz, Halldin C. Kinetic Analysis and Quantification of the Dopamine Transporter in the Nonhuman Primate Brain with 11C-PE2I and 18F-FE-PE2I. Journal of Nuclear Medicine. 2011;52(1):132-139.
  66. Viertl D, Bischof Delaloye A, Lanz B, Poitry-Yamate C, Gruetter R, Mlynarik V, Ametamey SM, Ross TL, Lehr HA, Andre PA, Perillo-Adamer F, Kosinski M, Dupertuis YM, Buchegger F. Increase of [(18)F]FLT Tumor Uptake In Vivo Mediated by FdUrd: Toward Improving Cell Proliferation Positron Emission Tomography. Mol Imaging Biol. 2011;13(2):321-31.
  67. Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O'Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, Reininger CB, Fels L, Putz B, Rohde B, Masters CL, Rowe CC. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. J Nucl Med. 2011;52(8):1210-7.
  68. von Forstner C, Zuhayra M, Ammerpohl O, Zhao Y, Tiwari S, Jansen O, Kalthoff H, Henze E, Egberts J-H. Expression of L amino acid transport system 1 and analysis of iodine-123-methyltyrosine tumor uptake in a pancreatic xenotransplantation model using fused high-resolution-micro-SPECT-MRI. Hepatobiliary Pancreatic Diseases International. 2011;10(1):30-37.
  69. Wang TC, Hsiao IT, Cheng YK, Wey SP, Yen TC, Lin KJ. Noninvasive monitoring of tumor growth in a rat glioma model: comparison between neurological assessment and animal imaging. J Neurooncol. 2011;104(3):669-78.
  70. Waterval JJ, Van Dongen TM, Stokroos RJ, Teule JG, Kemerink GJ, Brans B, Nieman FH, Manni JJ. Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET. Eur J Nucl Med Mol Imaging. 2011;38(5):884-93.
  71. Yamasaki T, Fujinaga M, Maeda J, Kawamura K, Yui J, Hatori A, Yoshida Y, Nagai Y, Tokunaga M, Higuchi M, Suhara T, Fukumura T, Zhang MR. Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [(18)F]FITM. Eur J Nucl Med Mol Imaging. 2011.
  72. Yamashita S, Takashima T, Kataoka M, Oh H, Sakuma S, Takahashi M, Suzuki N, Hayashinaka E, Wada Y, Cui Y, Watanabe Y. PET imaging of the gastrointestinal absorption of orally administered drugs in conscious and anesthetized rats. J Nucl Med. 2011;52(2):249-56.
  73. Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, Wakuda T, Sugihara G, Takebayashi K, Suda S, Iwata Y, Ueki T, Tsuchiya KJ, Suzuki K, Nakamura K, Ouchi Y. In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2011;38(2):343-51.
  74. Yui J, Hatori A, Kawamura K, Yanamoto K, Yamasaki T, Ogawa M, Yoshida Y, Kumata K, Fujinaga M, Nengaki N, Fukumura T, Suzuki K, Zhang M-R. Visualization of early infarction in rat brain after ischemia using a translocator protein (18kDa) PET ligand [11C]DAC with ultra-high specific activity. Neuroimage. 2011;54(1):123-130.
  75. Zanotti-Fregonara P, Zoghbi SS, Liow J-S, Luong E, Boellaard R, Gladding RL, Pike VW, Innis RB, Fujita M. Kinetic analysis in human brain of [11C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: A retest study and use of an image-derived input function. Neuroimage. 2011;54(3):1903-1909.
2010
  1. Alexanderson E, Ochoa JM, Calleja R, Juarez-Rojas JG, Prior JO, Jacome R, Romero E, Meave A, Posadas-Romero C. Endothelial Dysfunction in Systemic Lupus Erythematosus: Evaluation with 13N-Ammonia PET. J Nucl Med. 2010;51(12):1927-31.
  2. Andersson JD, Varnas K, Cselenyi Z, Gulyas B, Wensbo D, Finnema SJ, Swahn BM, Svensson S, Nyberg S, Farde L, Halldin C. Radiosynthesis of the candidate beta-amyloid radioligand [(11)C]AZD2184: Positron emission tomography examination and metabolite analysis in cynomolgus monkeys. Synapse. 2010;64(10):733-41.
  3. Assem-Hilger E, Lanzenberger R, Savli M, Wadsak W, Mitterhauser M, Mien L-K, Stögmann E, Baumgartner C, Kletter K, Asenbaum S. Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-11C]WAY-100635 PET study. Epilepsy & Behavior. 2010;19(3):467-473.
  4. Baumann CA, Mu L, Wertli N, Kramer SD, Honer M, Schubiger PA, Ametamey SM. Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands. Bioorg Med Chem. 2010.
  5. Biegon A, Kim SW, Logan J, Hooker JM, Muench L, Fowler JS. Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons. Biol Psychiatry. 2010;67(8):774-7.
  6. Blesa J, Juri C, Collantes M, Penuelas I, Prieto E, Iglesias E, Marti-Climent J, Arbizu J, Zubieta JL, Rodriguez-Oroz MC, Garcia-Garcia D, Richter JA, Cavada C, Obeso JA. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study. Neurobiol Dis. 2010;38(3):456-63.
  7. Burger C, Deschwanden A, Ametamey S, Johayem A, Mancosu B, Wyss M, Hasler G, Buck A. Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5. Nuclear Medicine and Biology. 2010;37(7):845-851.
  8. Burkhard N, Herzog BA, Husmann L, Pazhenkottil AP, Burger IA, Buechel RR, Valenta I, Wyss CA, Kaufmann PA. Coronary calcium score scans for attenuation correction of quantitative PET/CT (13)N-ammonia myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2010;37(3):517-21.
  9. Casteels C, Martinez E, Bormans G, Camon L, de Vera N, Baekelandt V, Planas AM, Van Laere K. Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism. Eur J Nucl Med Mol Imaging. 2010;37(12):2354-63.
  10. Casteels C, Bormans G, Van Laere K. The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain. Eur J Nucl Med Mol Imaging. 2010;37(6):1164-73.
  11. Celen S, Koole M, De Angelis M, Sannen I, Chitneni SK, Alcazar J, Dedeurwaerdere S, Moechars D, Schmidt M, Verbruggen A, Langlois X, Van Laere K, Andres JI, Bormans G. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain. J Nucl Med. 2010;51(10):1584-91.
  12. Christian N, Deheneffe S, Bol A, De Bast M, Labar D, Lee JA, Grégoire V. Is 18F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer 14C-EF3 in animal tumor models. Radiotherapy and Oncology. 2010;97(2):183-188.
  13. De Bruyne S, La Regina G, Staelens S, Wyffels L, Deleye S, Silvestri R, De Vos F. Radiosynthesis and in vivo evaluation of [11C]-labelled pyrrole-2-carboxamide derivates as novel radioligands for PET imaging of monoamine oxidase A. Nucl Med Biol. 2010;37(4):459-67.
  14. Dimitrakopoulou-Strauss A, Strauss LG, Egerer G, Vasamiliette J, Schmitt T, Haberkorn U, Kasper B. Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis. Eur J Nucl Med Mol Imaging. 2010;37(8):1481-9.
  15. Dukart J, Mueller K, Horstmann A, Vogt B, Frisch S, Barthel H, Becker G, Moller HE, Villringer A, Sabri O, Schroeter ML. Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage. 2010;49(2):1490-5.
  16. Doot RK, Muzi M, Peterson LM, Schubert EK, Gralow JR, Specht JM, Mankoff DA. Kinetic Analysis of 18F-Fluoride PET Images of Breast Cancer Bone Metastases. J Nucl Med. 2010.
  17. Elmenhorst D, Minuzzi L, Aliaga A, Rowley J, Massarweh G, Diksic M, Bauer A, Rosa-Neto P. In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688. J Cereb Blood Flow Metab. 2010;30(8):1538-49.
  18. Erritzoe D, Frokjaer VG, Haahr MT, Kalbitzer J, Svarer C, Holst KK, Hansen DL, Jernigan TL, Lehel S, Knudsen GM. Cerebral serotonin transporter binding is inversely related to body mass index. Neuroimage. 2010.
  19. Ettrup A, Palner M, Gillings N, Santini MA, Hansen M, Kornum BR, Rasmussen LK, Nagren K, Madsen J, Begtrup M, Knudsen GM. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET. J Nucl Med. 2010;51(11):1763-70.
  20. Goffin K, Van Paesschen W, Dupont P, Baete K, Palmini A, Nuyts J, Van Laere K. Anatomy-based reconstruction of FDG-PET images with implicit partial volume correction improves detection of hypometabolic regions in patients with epilepsy due to focal cortical dysplasia diagnosed on MRI. Eur J Nucl Med Mol Imaging. 2010;37(6):1148-55.
  21. Hanin FX, Pauwels S, Bol A, Breeman W, de Jong M, Jamar F. Tumor uptake of (68)Ga-DOTA-Tyr(3)-octreotate: animal PET studies of tumor flow and acute somatostatin receptor modulation in the CA20948 rat model. Nucl Med Biol. 2010;37(2):157-165.
  22. Heusner TA, Kuemmel S, Koeninger A, Hamami ME, Hahn S, Quinsten A, Bockisch A, Forsting M, Lauenstein T, Antoch G, Stahl A. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging. 2010;37(6):1077-86.
  23. Hoekzema E, Herance R, Rojas S, Pareto D, Abad S, Jiménez X, Figueiras FP, Popota F, Ruiz A, Torrent È, Fernández-Soriano FJ, Rocha M, Rovira M, Víctor VM, Gispert JD. The effects of aging on dopaminergic neurotransmission: a microPET study of [11C]-raclopride binding in the aged rodent brain. Neuroscience. 2010;171(4):1283-1286.
  24. Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C. Evaluation of [11C]metergoline as a PET radiotracer for 5HTR in nonhuman primates. Bioorganic & Medicinal Chemistry. 2010;18(22):7739-7745.
  25. Hsiao IT, Lin KJ, Chang SI, Yen TC, Chen TC, Yeh TS. Impaired liver regeneration of steatotic rats after portal vein ligation: a particular emphasis on (99m)Tc-DISIDA scintigraphy and adiponectin signaling. J Hepatol. 2010;52(4):540-9.
  26. Huang YY, Ma KH, Tseng TW, Chou TK, Ng H, Mirsalis JC, Fu YK, Chu TC, Huang WS, Shiue CY. Biodistribution, toxicity and radiation dosimetry studies of the serotonin transporter radioligand 4-[(18)F]-ADAM in rats and monkeys. Eur J Nucl Med Mol Imaging. 2010;37(3):545-55.
  27. Ichise M, Harris PE. Imaging of beta-cell mass and function. J Nucl Med. 2010;51(7):1001-4.
  28. Inabnet WB, Milone L, Harris P, Durak E, Freeby MJ, Ahmed L, Sebastian M, Lifante JC, Bessler M, Korner J. The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass. Surgery. 2010;147(2):303-9.
  29. Janssen MH, Ollers MC, van Stiphout RG, Buijsen J, van den Bogaard J, de Ruysscher D, Lambin P, Lammering G. Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings. Radiother Oncol. 2010;94(2):151-5.
  30. Janssen MH, Ollers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, Lambin P, Lammering G. Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer. Radiother Oncol. 2010;95(2):203-8.
  31. Kasper B, Dimitrakopoulou-Strauss A, Strauss LG, Hohenberger P. Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib. Eur J Nucl Med Mol Imaging. 2010;37(10):1876-82.
  32. Kawamura K, Naganawa M, Konno F, Yui J, Wakizaka H, Yamasaki T, Yanamoto K, Hatori A, Takei M, Yoshida Y, Sakaguchi K, Fukumura T, Kimura Y, Zhang MR. Imaging of I2-imidazoline receptors by small-animal PET using 2-(3-fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD). Nucl Med Biol. 2010;37(5):625-35.
  33. Kimura Y, Simeon FG, Hatazawa J, Mozley PD, Pike VW, Innis RB, Fujita M. Biodistribution and radiation dosimetry of a positron emission tomographic ligand, 18F-SP203, to image metabotropic glutamate subtype 5 receptors in humans. Eur J Nucl Med Mol Imaging. 2010;37(10):1943-9.
  34. Kreisl WC, Fujita M, Fujimura Y, Kimura N, Jenko KJ, Kannan P, Hong J, Morse CL, Zoghbi SS, Gladding RL, Jacobson S, Oh U, Pike VW, Innis RB. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage. 2010;49(4):2924-32.
  35. Kreisl WC, Liow JS, Kimura N, Seneca N, Zoghbi SS, Morse CL, Herscovitch P, Pike VW, Innis RB. P-Glycoprotein Function at the Blood-Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer 11C-N-Desmethyl-Loperamide. J Nucl Med. 2010.
  36. Kuntner C, Bankstahl JP, Bankstahl M, Stanek J, Wanek T, Stundner G, Karch R, Brauner R, Meier M, Ding X, Muller M, Loscher W, Langer O. Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[(11)C]verapamil PET. Eur J Nucl Med Mol Imaging. 2010;37(5):942-53.
  37. Kupers R, Frokjaer VG, Erritzoe D, Naert A, Budtz-Joergensen E, Nielsen FA, Kehlet H, Knudsen GM. Serotonin transporter binding in the hypothalamus correlates negatively with tonic heat pain ratings in healthy subjects: A [11C]DASB PET study. Neuroimage. 2011;54(2):1336-1343.
  38. Lambert B, Mertens J, Sturm EJ, Stienaers S, Defreyne L, D'Asseler Y. 99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres. Eur J Nucl Med Mol Imaging. 2010;37(12):2328-33.
  39. Lauzurica N, Garcia-Garcia L, Pinto S, Fuentes JA, Delgado M. Changes in NPY and POMC, but not serotonin transporter, following a restricted feeding/repletion protocol in rats. Brain Res. 2010;1313:103-12.
  40. Lee PW, Hsu SH, Wang JJ, Tsai JS, Lin KJ, Wey SP, Chen FR, Lai CH, Yen TC, Sung HW. The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. Biomaterials. 2010;31(6):1316-24.
  41. Lin CY, Chang YH, Lin KJ, Yen TC, Tai CL, Chen CY, Lo WH, Hsiao IT, Hu YC. The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials. 2010.
  42. Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, Yen TC, Kung MP. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study. Nucl Med Biol. 2010;37(4):497-508.
  43. Mathe D, Balogh L, Polyak A, Kiraly R, Marian T, Pawlak D, Zaknun JJ, Pillai MR, Janoki GA. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of (177)Lu-EDTMP, a potential bone pain palliation agent. Nucl Med Biol. 2010;37(2):215-226.
  44. Merron A, Baril P, Martin-Duque P, de la Vieja A, Tran L, Briat A, Harrington KJ, McNeish IA, Vassaux G. Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours. Eur J Nucl Med Mol Imaging. 2010;37(7):1377-85.
  45. Meyer PT, Bhagwagar Z, Cowen PJ, Cunningham VJ, Grasby PM, Hinz R. Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses. Neuroimage. 2010;50(3):984-93.
  46. Miyoshi M, Shinotoh H, Wszolek ZK, Strongosky AJ, Shimada H, Arakawa R, Higuchi M, Ikoma Y, Yasuno F, Fukushi K, Irie T, Ito H, Suhara T. In vivo detection of neuropathologic changes in presymptomatic MAPT mutation carriers: A PET and MRI study. Parkinsonism Relat Disord. 2010;16(6):404-408.
  47. Mizuma H, Shukuri M, Hayashi T, Watanabe Y, Onoe H. Establishment of in vivo brain imaging method in conscious mice. J Nucl Med. 2010;51(7):1068-75.
  48. Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, Ellis JR, Ackermann U, O'Keefe G, Jones G, Kung HF, Pontecorvo MJ, Skovronsky D, Rowe CC. In vivo measurement of vesicular monoamine transporter type 2 density in parkinson disease with (18)F-AV-133. J Nucl Med. 2010;51(2):223-8.
  49. Rominger A, Mille E, Zhang S, Boning G, Forster S, Nowak S, Gildehaus FJ, Wangler B, Bartenstein P, Cumming P. Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice. J Nucl Med. 2010;51(10):1576-83.
  50. Rommel D, Abarca-Quinones J, Bol A, Peeters F, Lhommel R, Lonneux M, Labar D, Gregoire V, Duprez T. Early monitoring of external radiation therapy by [18F]-fluoromethylcholine positron emission tomography and 3-T proton magnetic resonance spectroscopy: an experimental study in a rodent rhabdomyosarcoma model. Nucl Med Biol. 2010;37(5):645-53.
  51. Saba W, Valette H, Peyronneau MA, Bramoulle Y, Coulon C, Curet O, George P, Dolle F, Bottlaender M. [(11)C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: preclinical characterisation in nonhuman primate. Synapse. 2010;64(1):61-9
  52. Shi K, Souvatzoglou M, Astner ST, Vaupel P, Nusslin F, Wilkens JJ, Ziegler SI. Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors. J Nucl Med. 2010;51(9):1386-94.
  53. Skinbjerg M, Liow JS, Seneca N, Hong J, Lu S, Thorsell A, Heilig M, Pike VW, Halldin C, Sibley DR, Innis RB. D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model. Neuroimage. 2010;50(4):1402-7.
  54. Sonaje K, Lin KJ, Wey SP, Lin CK, Yeh TH, Nguyen HN, Hsu CW, Yen TC, Juang JH, Sung HW. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-Responsive nanoparticles vs. subcutaneous injection. Biomaterials. 2010;31(26):6849-58.
  55. Spinelli S, Chefer S, Carson RE, Jagoda E, Lang L, Heilig M, Barr CS, Suomi SJ, Higley JD, Stein EA. Effects of Early-Life Stress on Serotonin(1A) Receptors in Juvenile Rhesus Monkeys Measured by Positron Emission Tomography. Biol Psychiatry. 2010.
  56. Teragawa H, Morita K, Shishido H, Otsuka N, Hirokawa Y, Chayama K, Tamaki N, Kihara Y. Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia. Eur J Nucl Med Mol Imaging. 2010;37(2):368-76.
  57. Terry GE, Hirvonen J, Liow JS, Seneca N, Tauscher JT, Schaus JM, Phebus L, Felder CC, Morse CL, Pike VW, Halldin C, Innis RB. Biodistribution and dosimetry in humans of two inverse agonists to image cannabinoid CB1 receptors using positron emission tomography. Eur J Nucl Med Mol Imaging. 2010;37(8):1499-506.
  58. Van Camp N, Boisgard R, Kuhnast B, Theze B, Viel T, Gregoire MC, Chauveau F, Boutin H, Katsifis A, Dolle F, Tavitian B. In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [ (11)C]CLINME and [ (11)C]PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging. 2010;37(5):962-72.
  59. Van Laere K, Clerinx K, D'Hondt E, de Groot T, Vandenberghe W. Combined Striatal Binding and Cerebral Influx Analysis of Dynamic 11C-Raclopride PET Improves Early Differentiation Between Multiple-System Atrophy and Parkinson Disease. J Nucl Med. 2010.
  60. Wenzel F, Young S, Wilke F, Apostolova I, Arlt S, Jahn H, Thiele F, Buchert R. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis. Neuroimage. 2010;50(3):994-1003.
  61. Wu YW, Chen YH, Wang SS, Jui HY, Yen RF, Tzen KY, Chen MF, Lee CM. PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients. J Nucl Med. 2010;51(6):906-12.
  62. Yui J, Maeda J, Kumata K, Kawamura K, Yanamoto K, Hatori A, Yamasaki T, Nengaki N, Higuchi M, Zhang MR. 18F-FEAC and 18F-FEDAC: PET of the Monkey Brain and Imaging of Translocator Protein (18 kDa) in the Infarcted Rat Brain. J Nucl Med. 2010;51(8):1301-9.
  63. Yui J, Hatori A, Kawamura K, Yanamoto K, Yamasaki T, Ogawa M, Yoshida Y, Kumata K, Fujinaga M, Nengaki N, Fukumura T, Suzuki K, Zhang M-R. Visualization of early infarction in rat brain after ischemia using a translocator protein (18 kDa) PET ligand [11C]DAC with ultra-high specific activity. Neuroimage. 2011;54(1):123-130.
  64. Zanotti-Fregonara P, Zoghbi SS, Liow JS, Luong E, Boellaard R, Gladding RL, Pike VW, Innis RB, Fujita M. Kinetic analysis in human brain of [(11)C](R)-rolipram, a positron emission tomographic radioligand to image phosphodiesterase 4: A retest study and use of an image-derived input function. Neuroimage. 2011;54(3):1903-9
  65. Ziebell M, Holm-Hansen S, Thomsen G, Wagner A, Jensen P, Pinborg LH, Knudsen GM. Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123I-FP-CIT and 123I-PE2I. J Nucl Med. 2010;51(12):1885-91.
2009
  1. Arakawa R, Ichimiya T, Ito H, Takano A, Okumura M, Takahashi H, Takano H, Yasuno F, Kato M, Okubo Y, Suhara T. Increase in thalamic binding of [(11)C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. J Psychiatr Res. 2009;43(15):1219-23.
  2. Backes H, Ullrich R, Neumaier B, Kracht L, Wienhard K, Jacobs AH. Noninvasive quantification of (18)F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma. Eur J Nucl Med Mol Imaging. 2009.
  3. Bauer M, Karch R, Neumann F, Wagner CC, Kletter K, Muller M, Loscher W, Zeitlinger M, Langer O. Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier. J Cereb Blood Flow Metab. 2009.
  4. Ceccarini G, Flavell RR, Butelman ER, Synan M, Willnow TE, Bar-Dagan M, Goldsmith SJ, Kreek MJ, Kothari P, Vallabhajosula S, Muir TW, Friedman JM. PET imaging of leptin biodistribution and metabolism in rodents and primates. Cell Metab. 2009;10(2):148-59.
  5. Chauveau, F. et al. Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation. J Nucl Med. 2009;50, 468-476.
  6. Choi SJ, Kim SY, Kim SJ, Lee JS, Lee SJ, Park SA, Yun SC, Im KC, Oh SJ, Kim SW, Kim JS, Ryu JS, Moon DH. Reproducibility of the kinetic analysis of 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography in mouse tumor models. Nucl Med Biol. 2009;36(7):711-9. 2009;50(9):1479-82.
  7. Christian N, Lee JA, Bol A, De Bast M, Jordan B, Gregoire V. The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. Radiother Oncol. 2009;91(1):101-6.
  8. Collantes M, Prieto E, Penuelas I, Blesa J, Juri C, Marti-Climent JM, Quincoces G, Arbizu J, Riverol M, Zubieta JL, Rodriguez-Oroz MC, Luquin MR, Richter JA, Obeso JA. New MRI, 18F-DOPA and 11C-(+)-alpha-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: advantages to improve PET quantification. Neuroimage. 2009;47(2):533-9.
  9. Cui Y, Takashima T, Takashima-Hirano M, Wada Y, Shukuri M, Tamura Y, Doi H, Onoe H, Kataoka Y, Watanabe Y. 11C-PK11195 PET for the in vivo evaluation of neuroinflammation in the rat brain after cortical spreading depression. J Nucl Med. 2009;50(11):1904-11.
  10. Eyal S, Chung FS, Muzi M, Link JM, Mankoff DA, Kaddoumi A, O'Sullivan F, Hebert MF, Unadkat JD. Simultaneous PET Imaging of P-Glycoprotein Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate. J Nucl Med. 2009;50(5):798-806.
  11. Fink, M. et al. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. Neuroimage. 2009;45, 598-605.
  12. Frokjaer VG, Vinberg M, Erritzoe D, Svarer C, Baare W, Budtz-Joergensen E, Madsen K, Madsen J, Kessing LV, Knudsen GM. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. NeuroImage. 2009;46(2):360-6.
  13. Fujimura Y, Zoghbi SS, Simeon FG, Taku A, Pike VW, Innis RB, Fujita M. Quantification of Translocator Protein (18 kDa) in the Human Brain with PET and a Novel Radioligand, 18F-PBR06. J Nucl Med. 2009.
  14. Goffin K, Paesschen WV, Dupont P, Laere KV. Longitudinal microPET imaging of brain glucose metabolism in rat lithium-pilocarpine model of epilepsy. Exp Neurol. 2009;217(1):205-9.
  15. Goland, R. et al. 11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls. J Nucl Med. 2009; 50, 382-389.
  16. Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord. 2009;15(7):516-20.
  17. Goldstein DS, Holmes C, Sewell L, Kopin IJ. Hypertension Increases Cerebral 6-18F-Fluorodopa-Derived Radioactivity. J Nucl Med. 2009;50(9):1479-82.
  18. Grimmer T, Riemenschneider M, Forstl H, Henriksen G, Klunk WE, Mathis CA, Shiga T, Wester HJ, Kurz A, Drzezga A. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid. Biol Psychiatry. 2009;65(11):927-34.
  19. Haense C, Herholz K, Jagust WJ, Heiss WD. Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dement Geriatr Cogn Disord. 2009;28(3):259-66.
  20. Hautzel H, Mottaghy FM, Specht K, Muller HW, Krause BJ. Evidence of a modality-dependent role of the cerebellum in working memory? An fMRI study comparing verbal and abstract n-back tasks. NeuroImage. 2009;47(4):2073-82.
  21. Henriques de Figueiredo B, Barret O, Demeaux H, Lagarde P, De-Mones-Del-Pujol E, Kantor G, de Clermont-Gallerande H, Richaud P, Fernandez P. Comparison between CT- and FDG-PET-defined target volumes for radiotherapy planning in head-and-neck cancers. Radiother Oncol. 2009;93(3):479-82.
  22. Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, Burkhard N, Wyss CA, Kaufmann PA. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol. 2009;54(2):150-6.
  23. Hiraoka K, Okamura N, Funaki Y, Watanuki S, Tashiro M, Kato M, Hayashi A, Hosokai Y, Yamasaki H, Fujii T, Mori E, Yanai K, Watabe H. Quantitative analysis of donepezil binding to acetylcholinesterase using positron emission tomography and [5-(11)C-methoxy]donepezil. NeuroImage. 2009;46(3):616-23.
  24. Horigome M, Kumazaki S, Hattori N, Kasai H, Aizawa K, Izawa A, Tomita T, Tsutsui H, Koyama J, Sakurai S, Ikeda U. Noninvasive evaluation of coronary endothelial function following sirolimus-eluting stent implantation by using positron emission tomography. Cardiology. 2009;114(3):157-63.
  25. Itoh T, Abe K, Zoghbi SS, Inoue O, Hong J, Imaizumi M, Pike VW, Innis RB, Fujita M. PET Measurement of the In Vivo Affinity of 11C-(R)-Rolipram and the Density of Its Target, Phosphodiesterase-4, in the Brains of Conscious and Anesthetized Rats. J Nucl Med. 2009;50(5):749-756.
  26. Kalbitzer, J. et al. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage. 2009; 45, 280-5.
  27. Kempen DH, Yaszemski MJ, Heijink A, Hefferan TE, Creemers LB, Britson J, Maran A, Classic KL, Dhert WJ, Lu L. Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. J Control Release. 2009;134(3):169-76.
  28. Kim SW, Biegon A, Katsamanis ZE, Ehrlich CW, Hooker JM, Shea C, Muench L, Xu Y, King P, Carter P, Alexoff DL, Fowler JS. Reinvestigation of the synthesis and evaluation of [N-methyl-(11)C]vorozole, a radiotracer targeting cytochrome P450 aromatase. Nucl Med Biol. 2009;36(3):323-34.
  29. Knesaurek, K., Machac, J. & Zhang, Z. Repeatability of regional myocardial blood flow calculation in 82Rb PET imaging. BMC Med Phys. 2009;9, 2.
  30. Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, Vandenberghe R, Van Laere K. Whole-Body Biodistribution and Radiation Dosimetry of 18F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging. J Nucl Med. 2009;50(5):818-822.
  31. la Fougere C, Boning G, Bartmann H, Wangler B, Nowak S, Just T, Wagner E, Winter P, Rominger A, Forster S, Gildehaus FJ, Rosa-Neto P, Minuzzi L, Bartenstein P, Potschka H, Cumming P. Uptake and binding of the serotonin 5-HT(1A) antagonist [(18)F]-MPPF in brain of rats: Effects of the novel P-glycoprotein inhibitor tariquidar. Neuroimage. 2009
  32. Le Foll B, Chefer SI, Kimes AS, Shumway D, Stein EA, Mukhin AG, Goldberg SR. Baseline expression of alpha4beta2* nicotinic acetylcholine receptors predicts motivation to self-administer nicotine. Biol Psychiatry. 2009;65(8):714-6.
  33. Lin, K. J. et al. Improved hepatocyte function of future liver remnant of cirrhotic rats after portal vein ligation: a bonus other than volume shifting. Surgery. 2009; 145, 202-11.
  34. Lin KJ, Liu HL, Hsu PH, Chung YH, Huang WC, Chen JC, Wey SP, Yen TC, Hsiao IT. Quantitative micro-SPECT/CT for detecting focused ultrasound-induced blood-brain barrier opening in the rat. Nucl Med Biol. 2009;36(7):853-61.
  35. Liow, J. S. et al. P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys. J Nucl Med. 2009;50, 108-15.
  36. Liu, N. et al. PET-Based Biodistribution and Radiation Dosimetry of Epidermal Growth Factor Receptor-Selective Tracer 11C-PD153035 in Humans. J Nucl Med. 2009; 50, 303-308.
  37. Lucatelli C, Honer M, Salazar JF, Ross TL, Schubiger PA, Ametamey SM. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5. Nucl Med Biol. 2009;36(6):613-22.
  38. Martin A, Boisgard R, Theze B, Van Camp N, Kuhnast B, Damont A, Kassiou M, Dolle F, Tavitian B. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J Cereb Blood Flow Metab. 2009.
  39. Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y, Kosaka J, Arakawa R, Fujimura Y, Ota M, Takano A, Fukui K, Nakayama K, Suhara T. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. Neuroimage;49(1):121-6.
  40. Menda Y, Boles Ponto LL, Dornfeld KJ, Tewson TJ, Watkins GL, Schultz MK, Sunderland JJ, Graham MM, Buatti JM. Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy. J Nucl Med. 2009.
  41. Miyoshi M, Ito H, Arakawa R, Takahashi H, Takano H, Higuchi M, Okumura M, Otsuka T, Kodaka F, Sekine M, Sasaki T, Fujie S, Seki C, Maeda J, Nakao R, Zhang MR, Fukumura T, Matsumoto M, Suhara T. Quantitative Analysis of Peripheral Benzodiazepine Receptor in the Human Brain Using PET with 11C-AC-5216. J Nucl Med. 2009.
  42. Muzi M, Mankoff DA, Link JM, Shoner S, Collier AC, Sasongko L, Unadkat JD. Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy Humans. J Nucl Med. 2009;50(8):1267-75.
  43. Odano I, Halldin C, Karlsson P, Varrone A, Airaksinen AJ, Krasikova RN, Farde L. [18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil. NeuroImage. 2009;45(3):891-902.
  44. Otsuka T, Ito H, Halldin C, Takahashi H, Takano H, Arakawa R, Okumura M, Kodaka F, Miyoshi M, Sekine M, Seki C, Nakao R, Suzuki K, Finnema S, Hirayasu Y, Suhara T, Farde L. Quantitative PET Analysis of the Dopamine D2 Receptor Agonist Radioligand 11C-(R)-2-CH3O-N-n-Propylnorapomorphine in the Human Brain. J Nucl Med. 2009;50(5):703-710.
  45. Price SJ, Fryer TD, Cleij MC, Dean AF, Joseph J, Salvador R, Wang DD, Hutchinson PJ, Clark JC, Burnet NG, Pickard JD, Aigbirhio FI, Gillard JH. Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study. Clin Radiol. 2009;64(1):52-63.
  46. Ribeiro MJ, Thobois S, Lohmann E, du Montcel ST, Lesage S, Pelissolo A, Dubois B, Mallet L, Pollak P, Agid Y, Broussolle E, Brice A, Remy P. A Multitracer Dopaminergic PET Study of Young-Onset Parkinsonian Patients With and Without Parkin Gene Mutations. J Nucl Med. 2009;50(8):1244-1250.
  47. Seneca N, Zoghbi SS, Liow JS, Kreisl W, Herscovitch P, Jenko K, Gladding RL, Taku A, Pike VW, Innis RB. Human Brain Imaging and Radiation Dosimetry of 11C-N-Desmethyl-Loperamide, a PET Radiotracer to Measure the Function of P-Glycoprotein. J Nucl Med. 2009;50(5):807-13.
  48. Sosabowski JK, Matzow T, Foster JM, Finucane C, Ellison D, Watson SA, Mather SJ. Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide. J Nucl Med. 2009;50(12):2082-9.
  49. Takano A, Gulyas B, Varrone A, Maguire RP, Halldin C. Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2). Eur J Nucl Med Mol Imaging. 2009;36(8):1308-14.
  50. Takano A, Gulyas B, Varrone A, Halldin C. Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C] eNER. Eur J Nucl Med Mol Imaging. 2009;36(11):1892-5.
  51. Tantawy MN, Jones CK, Baldwin RM, Ansari MS, Conn PJ, Kessler RM, Peterson TE. [(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot. Nucl Med Biol. 2009;36(8):931-40.
  52. Teragawa H, Morita K, Shishido H, Otsuka N, Hirokawa Y, Chayama K, Tamaki N, Kihara Y. Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia. Eur J Nucl Med Mol Imaging. 2009.
  53. Terry GE, Liow JS, Zoghbi SS, Hirvonen J, Farris AG, Lerner A, Tauscher JT, Schaus JM, Phebus L, Felder CC, Morse CL, Hong JS, Pike VW, Halldin C, Innis RB. Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. NeuroImage. 2009;48(2):362-70.
  54. Valette H, Xiao Y, Peyronneau MA, Damont A, Kozikowski AP, Wei ZL, Kassiou M, Kellar KJ, Dolle F, Bottlaender M. 18F-ZW-104: A New Radioligand for Imaging Neuronal Nicotinic Acetylcholine Receptors--In Vitro Binding Properties and PET Studies in Baboons. J Nucl Med. 2009;50(8):1349-1355.
  55. Visigalli I, Moresco RM, Belloli S, Politi LS, Gritti A, Ungaro D, Matarrese M, Turolla E, Falini A, Scotti G, Naldini L, Fazio F, Biffi A. Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195. Neurobiol Dis. 2009;34(1):51-62.
  56. Wyss MT, Obrist NM, Haiss F, Eckert R, Stanley R, Burger C, Buck A, Weber B. A beta-scintillator for surface measurements of radiotracer kinetics in the intact rodent cortex. NeuroImage. 2009;48(2):339-47.
  57. Yamato, M., Kataoka, Y., Mizuma, H., Wada, Y. & Watanabe, Y. PET and Macro- and Microautoradiographic Studies Combined with Immunohistochemistry for Monitoring Rat Intestinal Ulceration and Healing Processes. J Nucl Med. 2009; 50, 266-73.
2008
  1. Arakawa R, Okumura M, Ito H, Seki C, Takahashi H, Takano H, Nakao R, Suzuki K, Okubo Y, Halldin C, Suhara T. Quantitative Analysis of Norepinephrine Transporter in the Human Brain Using PET with (S,S)-18F-FMeNER-D2. J Nucl Med. 2008;49(8):1270-1276.
  2. Barret O, Mazere J, Seibyl J, Allard M. Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging. J Cereb Blood Flow Metab. 2008;28(9):1624-34.
  3. Boecker H, Henriksen G, Sprenger T, Miederer I, Willoch F, Valet M, Berthele A, Tolle TR. Positron emission tomography ligand activation studies in the sports sciences: measuring neurochemistry in vivo. Methods. 2008;45(4):307-18.
  4. Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Haussinger D, Zilles K, Bauer A. Cerebral A(1) adenosine receptors (A(1)AR) in liver cirrhosis. Eur J Nucl Med Mol Imaging. 2008;35(3):589-97.
  5. Brown AK, Kimura Y, Zoghbi SS, Simeon FG, Liow JS, Kreisl WC, Taku A, Fujita M, Pike VW, Innis RB. Metabotropic Glutamate Subtype 5 Receptors Are Quantified in the Human Brain with a Novel Radioligand for PET. J Nucl Med. 2008;49(12):2042-8.
  6. Christian N, Lee JA, Bol A, De Bast M, Gallez B, Gregoire V. Immobilization device for in vivo and in vitro multimodality image registration of rodent tumors. Radiother Oncol. 2008;87(1):147-51.
  7. Chowdhury, I., Sengupta, A. & Maitra, S. K. Melatonin: fifty years of scientific journey from the discovery in bovine pineal gland to delineation of functions in human. Indian J Biochem Biophys 45, 289-304 (2008).
  8. Cropley VL, Fujita M, Bara-Jimenez W, Brown AK, Zhang XY, Sangare J, Herscovitch P, Pike VW, Hallett M, Nathan PJ, Innis RB. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA. Psychiatry Res. 2008;163(2):171-82.
  9. Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, Dekosky S, Wester HJ, Schwaiger M, Kurz A. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage. 2008;39(2):619-33.
  10. Feola M, Chauvie S, Rosso GL, Biggi A, Ribichini F, Bobbio M. Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study. J Nucl Cardiol. 2008;15(6):811-7.
  11. Frokjaer VG, Pinborg LH, Madsen J, de Nijs R, Svarer C, Wagner A, Knudsen GM. Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans. J Nucl Med. 2008;49(2):247-54.
  12. Fujita M, Imaizumi M, Zoghbi SS, Fujimura Y, Farris AG, Suhara T, Hong J, Pike VW, Innis RB. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage. 2008;40(1):43-52.
  13. Gerstl F, Windischberger C, Mitterhauser M, Wadsak W, Holik A, Kletter K, Moser E, Kasper S, Lanzenberger R. Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET. Neuroimage. 2008;41(2):204-11.
  14. Goffin K, Bormans G, Casteels C, Bosier B, Lambert DM, Grachev ID, Van Paesschen W, Van Laere K. An in vivo [(18)F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam. Neuropharmacology. 2008;54(7):1103-6.
  15. Goldstein DS, Holmes C, Bentho O, Sato T, Moak J, Sharabi Y, Imrich R, Conant S, Eldadah BA. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord. 2008;14(8):600-7.
  16. Herzog H, Elmenhorst D, Winz O, Bauer A. Biodistribution and radiation dosimetry of the A(1) adenosine receptor ligand (18)F-CPFPX determined from human whole-body PET. Eur J Nucl Med Mol Imaging. 2008;35(8):1499-506.
  17. Hjornevik T, Jacobsen LM, Qu H, Bjaalie JG, Gjerstad J, Willoch F. Metabolic plasticity in the supraspinal pain modulating circuitry after noxious stimulus-induced spinal cord LTP. Pain. 2008;140(3):456-64.
  18. Hooker JM, Xu Y, Schiffer W, Shea C, Carter P, Fowler JS. Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans. Neuroimage. 2008;41(3):1044-50.
  19. Ichise M, Cohen RM, Carson RE. Noninvasive estimation of normalized distribution volume: application to the muscarinic-2 ligand [(18)F]FP-TZTP. J Cereb Blood Flow Metab. 2008;28(2):420-30.
  20. Imaizumi M, Briard E, Zoghbi SS, Gourley JP, Hong J, Fujimura Y, Pike VW, Innis RB, Fujita M. Brain and whole-body imaging in nonhuman primates of [11C]PBR28, a promising PET radioligand for peripheral benzodiazepine receptors. Neuroimage. 2008;39(3):1289-98.
  21. Jentzen W, Weise R, Kupferschlager J, Freudenberg L, Brandau W, Bares R, Burchert W, Bockisch A. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems. Eur J Nucl Med Mol Imaging. 2008;35(3):611-23.
  22. Kim SJ, Lee JS, Im KC, Kim SY, Park SA, Lee SJ, Oh SJ, Lee DS, Moon DH. Kinetic Modeling of 3'-Deoxy-3'-18F-Fluorothymidine for Quantitative Cell Proliferation Imaging in Subcutaneous Tumor Models in Mice. J Nucl Med. 2008;49(12):2057-2066.
  23. Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Vaupel DB, Stein EA, Mukhin AG. Quantification of nicotinic acetylcholine receptors in the human brain with PET: Bolus plus infusion administration of 2-[(18)F]F-A85380. Neuroimage. 2008;39(2):717-27.
  24. Lodge MA, Jacene HA, Pili R, Wahl RL. Reproducibility of Tumor Blood Flow Quantification with 15O-Water PET. J Nucl Med. 2008;49(10):1620-1627.
  25. Mazere J, Prunier C, Barret O, Guyot M, Hommet C, Guilloteau D, Dartigues JF, Auriacombe S, Fabrigoule C, Allard M. In vivo SPECT imaging of vesicular acetylcholine transporter using [(123)I]-IBVM in early Alzheimer's disease. Neuroimage. 2008;40(1):280-8.
  26. McGoron, A. J. et al. Post traumatic brain perfusion SPECT analysis using reconstructed ROI maps of radioactive microsphere derived cerebral blood flow and statistical parametric mapping. BMC Med Imaging 8, 4 (2008).
  27. Meyer PT, Sattler B, Winz OH, Fundke R, Oehlwein C, Kendziorra K, Hesse S, Schaefer WM, Sabri O. Kinetic analyses of [(123)I]IBZM SPECT for quantification of striatal dopamine D2 receptor binding: A critical evaluation of the single-scan approach. Neuroimage. 2008;42(2):548-58.
  28. Meyer PT, Circiumaru V, Cardi CA, Thomas DH, Bal H, Acton PD. Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function. Eur J Nucl Med Mol Imaging. 2006;33(8):948-54.
  29. Millet P, Moulin M, Bartoli A, Del Guerra A, Ginovart N, Lemoucheux L, Buono S, Fagret D, Charnay Y, Ibanez V. In vivo quantification of 5-HT(1A)-[(18)F]MPPF interactions in rats using the YAP-(S)PET scanner and a beta-microprobe. Neuroimage. 2008;41(3):823-34.
  30. Mukhin AG, Kimes AS, Chefer SI, Matochik JA, Contoreggi CS, Horti AG, Vaupel DB, Pavlova O, Stein EA. Greater Nicotinic Acetylcholine Receptor Density in Smokers Than in Nonsmokers: A PET Study with 2-18F-FA-85380. J Nucl Med. 2008;49(10):1628-1635.
  31. Okumura M, Arakawa R, Ito H, Seki C, Takahashi H, Takano H, Haneda E, Nakao R, Suzuki H, Suzuki K, Okubo Y, Suhara T. Quantitative analysis of NK1 receptor in the human brain using PET with 18F-FE-SPA-RQ. J Nucl Med. 2008;49(11):1749-55.
  32. Patel VD, Lee DE, Alexoff DL, Dewey SL, Schiffer WK. Imaging dopamine release with Positron Emission Tomography (PET) and (11)C-raclopride in freely moving animals. Neuroimage. 2008;41(3):1051-66.
  33. Pierson ME, Andersson J, Nyberg S, McCarthy DJ, Finnema SJ, Varnas K, Takano A, Karlsson P, Gulyas B, Medd AM, Lee CM, Powell ME, Heys JR, Potts W, Seneca N, Mrzljak L, Farde L, Halldin C. [(11)C]AZ10419369: A selective 5-HT(1B) receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain. Neuroimage. 2008;41(3):1075-85.
  34. Rommel D, Abarca-Quinones J, Christian N, Peeters F, Lonneux M, Labar D, Bol A, Gregoire V, Duprez T. Alginate moulding: an empirical method for magnetic resonance imaging/positron emission tomography co-registration in a tumor rat model. Nucl Med Biol. 2008;35(5):571-7.
  35. Shih YY, Chiang YC, Chen JC, Huang CH, Chen YY, Liu RS, Chang C, Jaw FS. Brain nociceptive imaging in rats using (18)f-fluorodeoxyglucose small-animal positron emission tomography. Neuroscience. 2008;155(4):1221-6.
  36. Shidahara M, Ikoma Y, Seki C, Fujimura Y, Naganawa M, Ito H, Suhara T, Kanno I, Kimura Y. Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with (18)F-FEDAA1106. Eur J Nucl Med Mol Imaging. 2008;35(2):416-23.
  37. Siegrist PT, Comte N, Holzmeister J, Sutsch G, Koepfli P, Namdar M, Duru F, Brunckhorst C, Scharf C, Kaufmann PA. Effects of AV delay programming on ventricular resynchronisation: role of radionuclide ventriculography. Eur J Nucl Med Mol Imaging. 2008;35(8):1516-22.
  38. Siegrist PT, Husmann L, Knabenhans M, Gaemperli O, Valenta I, Hoefflinghaus T, Scheffel H, Stolzmann P, Alkadhi H, Kaufmann PA. (13)N-ammonia myocardial perfusion imaging with a PET/CT scanner: impact on clinical decision making and cost-effectiveness. Eur J Nucl Med Mol Imaging. 2008;35(5):889-95.
  39. Sotgia, B. et al. Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med 49, 1090-6 (2008).
  40. Sprague DR, Fujita M, Ryu YH, Liow JS, Pike VW, Innis RB. Whole-body biodistribution and radiation dosimetry in monkeys and humans of the phosphodiesterase 4 radioligand [(11)C](R)-rolipram: comparison of two-dimensional planar, bisected and quadrisected image analyses. Nucl Med Biol. 2008;35(4):493-500.
  41. Strauss LG, Koczan D, Klippel S, Pan L, Cheng C, Willis S, Haberkorn U, Dimitrakopoulou-Strauss A. Impact of Angiogenesis-Related Gene Expression on the Tracer Kinetics of 18F-FDG in Colorectal Tumors. J Nucl Med. 2008;49(8):1238-1244.
  42. Terry G, Liow JS, Chernet E, Zoghbi SS, Phebus L, Felder CC, Tauscher J, Schaus JM, Pike VW, Halldin C, Innis RB. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB(1) receptors in rodents. Neuroimage. 2008;41(3):690-8.
  43. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND. The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. Synapse 2008; 62:319-324.
  44. Thanos PK, Michaelides M, Piyis YK, Wang GJ, Volkow ND. Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography. Synapse 2008; 62:50-61.
  45. Van Laere K, Goffin K, Casteels C, Dupont P, Mortelmans L, de Hoon J, Bormans G. Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. Neuroimage. 2008;39(4):1533-41.
  46. Van Laere K, Koole M, Sanabria Bohorquez SM, Goffin K, Guenther I, Belanger MJ, Cote J, Rothenberg P, De Lepeleire I, Grachev ID, Hargreaves RJ, Bormans G, Burns HD. Whole-body biodistribution and radiation dosimetry of the human cannabinoid type-1 receptor ligand 18F-MK-9470 in healthy subjects. J Nucl Med. 2008;49(3):439-45.
  47. Van Laere K, Bormans G, Sanabria-Bohorquez SM, de Groot T, Dupont P, De Lepeleire I, de Hoon J, Mortelmans L, Hargreaves RJ, Atack JR, Burns HD. In vivo characterization and dynamic receptor occupancy imaging of TPA023B, an alpha 2/alpha 3/alpha 5 subtype selective gamma-aminobutyric acid-a partial agonist. Biol Psychiatry. 2008;64(2):153-61.
  48. von Forstner C, Egberts JH, Ammerpohl O, Niedzielska D, Buchert R, Mikecz P, Schumacher U, Peldschus K, Adam G, Pilarsky C, Grutzmann R, Kalthoff H, Henze E, Brenner W. Gene Expression Patterns and Tumor Uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an Orthotopic Mouse Xenotransplantation Model of Pancreatic Cancer. J Nucl Med. 2008;49(8):1362-1370.
  49. Wullner U, Gundisch D, Herzog H, Minnerop M, Joe A, Warnecke M, Jessen F, Schutz C, Reinhardt M, Eschner W, Klockgether T, Schmaljohann J. Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain. Neurosci Lett. 2008;430(1):34-7.
  50. Yasuno F, Ota M, Kosaka J, Ito H, Higuchi M, Doronbekov TK, Nozaki S, Fujimura Y, Koeda M, Asada T, Suhara T. Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106. Biol Psychiatry. 2008;64(10):835-41.
  51. Zoghbi SS, Liow JS, Yasuno F, Hong J, Tuan E, Lazarova N, Gladding RL, Pike VW, Innis RB. 11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux. J Nucl Med. 2008;49(4):649-56.
2007
  1. Adachi I, Gaemperli O, Valenta I, Schepis T, Siegrist PT, Treyer V, Burger C, Morita K, Kaufmann PA. Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: validation of a new fast factor analysis. J Nucl Cardiol. 2007;14(5):698-705.
  2. Ametamey SM, Treyer V, Streffer J, Wyss MT, Schmidt M, Blagoev M, Hintermann S, Auberson Y, Gasparini F, Fischer UC, Buck A. Human PET Studies of Metabotropic Glutamate Receptor Subtype 5 with 11C-ABP688. J Nucl Med. 2007;48(2):247-252.
  3. Boutin H, Chauveau F, Thominiaux C, Gregoire MC, James ML, Trebossen R, Hantraye P, Dolle F, Tavitian B, Kassiou M. 11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation. J Nucl Med. 2007;48(4):573-581.
  4. Brown AK, Fujita M, Fujimura Y, Liow JS, Stabin M, Ryu YH, Imaizumi M, Hong J, Pike VW, Innis RB. Radiation Dosimetry and Biodistribution in Monkey and Man of 11C-PBR28: A PET Radioligand to Image Inflammation. J Nucl Med. 2007;48(12):2072-2079.
  5. Dimitrakopoulou-Strauss A, Hohenberger P, Haberkorn U, Macke HR, Eisenhut M, Strauss LG. 68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG. J Nucl Med. 2007;48(8):1245-50.
  6. Doyle B, Kemp BJ, Chareonthaitawee P, Reed C, Schmeckpeper J, Sorajja P, Russell S, Araoz P, Riederer SJ, Caplice NM. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. J Nucl Med. 2007;48(10):1708-14.
  7. Elmenhorst D, Meyer PT, Matusch A, Winz OH, Zilles K, Bauer A. Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET. Eur J Nucl Med Mol Imaging. 2007;34(7):1061-70.
  8. Frumberg DB, Fernando MS, Lee DE, Biegon A, Schiffer WK. Metabolic and behavioral deficits following a routine surgical procedure in rats. Brain Res. 2007;1144:209-18.
  9. Ginovart N, Willeit M, Rusjan P, Graff A, Bloomfield PM, Houle S, Kapur S, Wilson AA. Positron emission tomography quantification of [(11)C]-(+)-PHNO binding in the human brain. J Cereb Blood Flow Metab. 2007;27(4):857-871.
  10. Haberkorn U, Hoffend J, Schmidt K, Altmann A, Bonaterra GA, Dimitrakopoulou-Strauss A, Strauss LG, Eisenhut M, Kinscherf R. Changes in glucose metabolism and gene expression after transfer of anti-angiogenic genes in rat hepatoma. Eur J Nucl Med Mol Imaging. 2007.
  11. Honer M, Stoffel A, Kessler LJ, Schubiger PA, Ametamey SM. Radiolabeling and in vitro and in vivo evaluation of [(18)F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5. Nucl Med Biol. 2007;34(8):973-80.
  12. Imaizumi M, Kim HJ, Zoghbi SS, Briard E, Hong J, Musachio JL, Ruetzler C, Chuang DM, Pike VW, Innis RB, Fujita M. PET imaging with [(11)C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett. 2007;411(3):200-5.
  13. Jentzen W, Freudenberg L, Eising EG, Heinze M, Brandau W, Bockisch A. Segmentation of PET Volumes by Iterative Image Thresholding. J Nucl Med. 2007;48(1):108-14.
  14. Kim SW, Ding YS, Alexoff D, Patel V, Logan J, Lin KS, Shea C, Muench L, Xu Y, Carter P, King P, Constanzo JR, Ciaccio JA, Fowler JS. Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug. Nucl Med Biol. 2007;34(5):541-51.
  15. Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry. 2007;61(9):1081-9.
  16. Lauwers E, Beque D, Van Laere K, Nuyts J, Bormans G, Mortelmans L, Casteels C, Vercammen L, Bockstael O, Nuttin B, Debyser Z, Baekelandt V. Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression. Neurobiol Aging. 2007;28(2):248-57.
  17. Le Foll B, Chefer SI, Kimes AS, Shumway D, Goldberg SR, Stein EA, Mukhin AG. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380. J Nucl Med. 2007;48(9):1492-500.
  18. Leroy C, Comtat C, Trebossen R, Syrota A, Martinot JL, Ribeiro MJ. Assessment of 11C-PE2I Binding to the Neuronal Dopamine Transporter in Humans with the High-Spatial-Resolution PET Scanner HRRT. J Nucl Med. 2007;48(4):538-46.
  19. Love Z, Wang F, Dennis J, Awadallah A, Salem N, Lin Y, Weisenberger A, Majewski S, Gerson S, Lee Z. Imaging of mesenchymal stem cell transplant by bioluminescence and PET. J Nucl Med. 2007;48(12):2011-20.
  20. Maeda J, Higuchi M, Inaji M, Ji B, Haneda E, Okauchi T, Zhang MR, Suzuki K, Suhara T. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Brain Res. 2007;1157:100-11.
  21. Mather SJ, McKenzie AJ, Sosabowski JK, Morris TM, Ellison D, Watson SA. Selection of radiolabeled gastrin analogs for Peptide receptor-targeted radionuclide therapy. J Nucl Med. 2007;48(4):615-22.
  22. Matusch A, Hurlemann R, Rota Kops E, Winz OH, Elmenhorst D, Herzog H, Zilles K, Bauer A. Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans. J Neural Transm. 2007;114(11):1433-42.
  23. Meyer PT, Elmenhorst D, Boy C, Winz O, Matusch A, Zilles K, Bauer A. Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans. Neurobiol Aging. 2007;28(12):1914-24.
  24. Mirrione MM, Schiffer WK, Fowler JS, Alexoff DL, Dewey SL, Tsirka SE. A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. Neuroimage. 2007;38(1):34-42.
  25. Mitterhauser M, Toegel S, Wadsak W, Lanzenberger RR, Mien LK, Kuntner C,Wanek T, Eidherr H, Ettlinger DE, Viernstein H, Kluger R, Dudczak R,Kletter K. Pre vivo, ex vivo and in vivo evaluations of [(68)Ga]-EDTMP. Nucl Med Biol. 2007;34(4):391-397.
  26. Miyata J, Hirao K, Namiki C, Fukuyama H, Okada T, Miki Y, Hayashi T, Murai T. Interfrontal commissural abnormality in schizophrenia: tractography-assisted callosal parcellation. Schizophr Res. 2007;97(1-3):236-41.
  27. Oishi N, Hashikawa K, Yoshida H, Ishizu K, Ueda M, Kawashima H, Saji H, Fukuyama H. Quantification of nicotinic acetylcholine receptors in Parkinson's disease with (123)I-5IA SPECT. J Neurol Sci. 2007;256(1-2):52-60.
  28. Penuelas I, Aranguren XL, Abizanda G, Marti-Climent JM, Uriz M, Ecay M, Collantes M, Quincoces G, Richter JA, Prosper F. (13)N-ammonia PET as a measurement of hindlimb perfusion in a mouse model of peripheral artery occlusive disease. J Nucl Med. 2007;48(7):1216-23.
  29. Rodriguez-Gomez JA, Lu JQ, Velasco I, et al. Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease. Stem Cells 2007; 25:918-928.
  30. Praschak-Rieder N, Kennedy J, Wilson AA, Hussey D, Boovariwala A, Willeit M, Ginovart N, Tharmalingam S, Masellis M, Houle S, Meyer JH. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol Psychiatry. 2007;62(4):327-31.
  31. Ryu YH, Liow JS, Zoghbi S, Fujita M, Collins J, Tipre D, Sangare J, Hong J, Pike VW, Innis RB. Disulfiram inhibits defluorination of (18)F-FCWAY, reduces bone radioactivity, and enhances visualization of radioligand binding to serotonin 5-HT1A receptors in human brain. J Nucl Med. 2007;48(7):1154-61.
  32. Seneca N, Cai L, Liow JS, Zoghbi SS, Gladding RL, Hong J, Pike VW, Innis RB. Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaques. Nucl Med Biol. 2007;34(6):681-9.
  33. Schepis T, Gaemperli O, Treyer V, Valenta I, Burger C, Koepfli P, Namdar M, Adachi I, Alkadhi H, Kaufmann PA. Absolute quantification of myocardial blood flow with 13N-ammonia and 3-dimensional PET. J Nucl Med. 2007;48(11):1783-9.
  34. Schiffer WK, Mirrione MM, Dewey SL. Optimizing Experimental Protocols for Quantitative Behavioral Imaging with 18F-FDG in Rodents. J Nucl Med. 2007;48(2):277-87.
  35. Shetty HU, Zoghbi SS, Liow JS, Ichise M, Hong J, Musachio JL, Halldin C, Seidel J, Innis RB, Pike VW. Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [(11)C]PE2I. Eur J Nucl Med Mol Imaging. 2007;34(5):667-78.
  36. Sprague DR, Chin FT, Liow JS, Fujita M, Burns HD, Hargreaves R, Stubbs JB, Pike VW, Innis RB, Mozley PD. Human Biodistribution and Radiation Dosimetry of the Tachykinin NK1 Antagonist Radioligand [18F]SPA-RQ: Comparison of Thin-Slice, Bisected, and 2-Dimensional Planar Image Analysis. J Nucl Med. 2007;48(1):100-7.
  37. Strobel K, Burger C, Schneider P, Weber M, Hany TF. MIBG-SPECT/CT-angiography with 3-D reconstruction of an extra-adrenal phaeochromocytoma with dissection of an aortic aneurysm. Eur J Nucl Med Mol Imaging. 2007;34(1):150.
  38. Takano A, Arakawa R, Hayashi M, Takahashi H, Ito H, Suhara T. Relationship between neuroticism personality trait and serotonin transporter binding. Biol Psychiatry. 2007;62(6):588-92.
  39. Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND. Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents. Pharmacol Biochem Behav. 2007;87(4):426-33.
  40. Treyer V, Streffer J, Wyss MT, Bettio A, Ametamey SM, Fischer U, Schmidt M, Gasparini F, Hock C, Buck A. Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods. J Nucl Med. 2007;48(7):1207-15.
  41. Vaupel DB, Stein EA, Mukhin AG. Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET(R) and 2-[(18)F]F-A-85380. Neuroimage. 2007;34:1352-1362.
  42. Wagenknecht G. Acontour tracing and coding algorithm for generating 2D contour codes from 3D classified objects. Pattern Recognition 40 (2007) 1294 - 1306.
  43. Wyss MT, Ametamey SM, Treyer V, Bettio A, Blagoev M, Kessler LJ, Burger C, Weber B, Schmidt M, Gasparini F, Buck A. Quantitative evaluation of (11)C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator. Neuroimage. 2007;35(3):1086-92.
  44. Wyss MT, Spaeth N, Biollaz G, Pahnke J, Alessi P, Trachsel E, Treyer V, Weber B, Neri D, Buck A. Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 Gliomas and Correlation with 131I-SIP(L19), a Marker of Angiogenesis. J Nucl Med. 2007;48(4):608-614.
  45. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron. 2007;53(3):337-51.
  46. Zappe AC, Reichold J, Burger C, Weber B, Buck A, Pfeuffer J, Logothetis NK. Quantification of cerebral blood flow in nonhuman primates using arterial spin labeling and a two-compartment model. Magn Reson Imaging. 2007;25(6):775-83.
  47. Zhang MR, Kumata K, Maeda J, Yanamoto K, Hatori A, Okada M, Higuchi M, Obayashi S, Suhara T, Suzuki K. 11C-AC-5216: a novel PET ligand for peripheral benzodiazepine receptors in the primate brain. J Nucl Med. 2007;48(11):1853-61.
2006
  1. Ametamey SM, Kessler LJ, Honer M, Wyss MT, Buck A, Hintermann S, Auberson YP, Gasparini F, Schubiger PA. Radiosynthesis and Preclinical Evaluation of 11C-ABP688 as a Probe for Imaging the Metabotropic Glutamate Receptor Subtype 5. J Nucl Med. 2006;47(4):698-705.
  2. Araya R, Noguchi T, Yuhki M, Kitamura N, Higuchi M, Saido TC, Seki K, Itohara S, Kawano M, Tanemura K, Takashima A, Yamada K, Kondoh Y, Kanno I, Wess J, Yamada M. Loss of M(5) muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis. 2006;24(2):334-44.
  3. Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Abrahim A, Lanzenberger R, Hofmann A, Joukhadar C, Carminati P, Ghirardi O, Piovesan P, Forloni G, Corrado ME, Lods N, Dudczak R, Auff E, Kletter K, Muller M. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Clin Pharmacol Ther. 2006;80(3):216-27.
  4. Berding G, Schneider U, Gielow P, Buchert R, Donnerstag F, Brandau W, Knapp WH, Emrich HM, Muller-Vahl K. Feasibility of central cannabinoid CB(1) receptor imaging with [(124)I]AM281 PET demonstrated in a schizophrenic patient. Psychiatry Res. 2006;147(2-3):249-56.
  5. Bettio A, Honer M, Muller C, Bruhlmeier M, Muller U, Schibli R, Groehn V, Schubiger AP, Ametamey SM. Synthesis and Preclinical Evaluation of a Folic Acid Derivative Labeled with 18F for PET Imaging of Folate Receptor-Positive Tumors. J Nucl Med. 2006;47(7):1153-1160.
  6. Casteels C, Vermaelen P, Nuyts J, Van Der Linden A, Baekelandt V, Mortelmans L, Bormans G, Van Laere K. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. J Nucl Med. 2006;47(11):1858-66.
  7. Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, Klaver JM, Charney DS, Manji HK, Drevets WC. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry. 2006;60(3):207-17.
  8. Chareonthaitawee P, Christenson SD, Anderson JL, Kemp BJ, Hodge DO, Ritman EL, Gibbons RJ. Reproducibility of Measurements of Regional Myocardial Blood Flow in a Model of Coronary Artery Disease: Comparison of H215O and 13NH3 PET Techniques. J Nucl Med. 2006;47(7):1193-1201.
  9. Cropley VL, Fujita M, Musachio JL, Hong J, Ghose S, Sangare J, Nathan PJ, Pike VW, Innis RB. Whole-Body Biodistribution and Estimation of Radiation-Absorbed Doses of the Dopamine D1 Receptor Radioligand 11C-NNC 112 in Humans. J Nucl Med. 2006;47(1):100-4.
  10. Dimitrakopoulou-Strauss A, Georgoulias V, Eisenhut M, Herth F, Koukouraki S, Macke HR, Haberkorn U, Strauss LG. Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET. Eur J Nucl Med Mol Imaging. 2006;33(7):823-30.
  11. Fujimura Y, Ikoma Y, Yasuno F, Suhara T, Ota M, Matsumoto R, Nozaki S, Takano A, Kosaka J, Zhang MR, Nakao R, Suzuki K, Kato N, Ito H. Quantitative Analyses of 18F-FEDAA1106 Binding to Peripheral Benzodiazepine Receptors in Living Human Brain. J Nucl Med. 2006;47(1):43-50.
  12. Fujita M, Ichise M, Zoghbi SS, Liow JS, Ghose S, Vines DC, Sangare J, Lu JQ, Cropley VL, Iida H, Kim KM, Cohen RM, Bara-Jimenez W, Ravina B, Innis RB. Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease. Ann Neurol. 2006;59(1):174-7.
  13. Honer M, Hengerer B, Blagoev M, Hintermann S, Waldmeier P, Schubiger PA, Ametamey SM. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice. Nucl Med Biol. 2006;33(5):607-14.
  14. Ikoma Y, Yasuno F, Ito H, Suhara T, Ota M, Toyama H, Fujimura Y, Takano A, Maeda J, Zhang MR, Nakao R, Suzuki K. Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106. J Cereb Blood Flow Metab. 2006.
  15. Ikoma Y, Takano A, Ito H, Kusuhara H, Sugiyama Y, Arakawa R, Fukumura T, Nakao R, Suzuki K, Suhara T. Quantitative analysis of 11C-verapamil transfer at the human blood-brain barrier for evaluation of P-glycoprotein function. J Nucl Med. 2006;47(9):1531-7.
  16. Kim JS, Ichise M, Sangare J, Innis RB. PET Imaging of Serotonin Transporters with [11C]DASB: Test-Retest Reproducibility Using a Multilinear Reference Tissue Parametric Imaging Method. J Nucl Med. 2006;47(2):208-214.
  17. Knoch D, Treyer V, Regard M, Muri RM, Buck A, Weber B. Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. Neuroimage. 2006;31(2):641-8.
  18. Koukouraki S, Strauss LG, Georgoulias V, Eisenhut M, Haberkorn U, Dimitrakopoulou-Strauss A. Comparison of the pharmacokinetics of (68)Ga-DOTATOC and [ (18)F]FDG in patients with metastatic neuroendocrine tumours scheduled for (90)Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging. 2006;33(10):1115-22.
  19. Kunz P, Hoffend J, Altmann A, Dimitrakopoulou-Strauss A, Koczan D, Eisenhut M, Bonaterra GA, Dengler TJ, Mier W, Haberkorn U, Kinscherf R. Angiopoietin-2 overexpression in morris hepatoma results in increased tumor perfusion and induction of critical angiogenesis-promoting genes. J Nucl Med. 2006;47(9):1515-24.
  20. Lin KJ, Liu CY, Wey SP, Hsiao IT, Wu J, Fu YK, Yen TC. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects. Nucl Med Biol. 2006;33(2):193-202.
  21. Matusch A, Meyer PT, Bier D, Holschbach MH, Woitalla D, Elmenhorst D, Winz OH, Zilles K, Bauer A. Metabolism of the A(1) adenosine receptor PET ligand [(18)F]CPFPX by CYP1A2: implications for bolus/infusion PET studies. Nucl Med Biol. 2006;33(7):891-8.
  22. Meyer PT, Elmenhorst D, Matusch A, Winz O, Zilles K, Bauer A. 18F-CPFPX PET: On the Generation of Parametric Images and the Effect of Scan Duration. J Nucl Med. 2006;47(2):200-7.
  23. Meyer PT, Elmenhorst D, Matusch A, Winz O, Zilles K, Bauer A. A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans. Neuroimage. 2006;32(3):1100-5.
  24. Mirrione MM, Schiffer WK, Siddiq M, Dewey SL, Tsirka SE. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse. 2006;59(2):119-21.
  25. Muzi M, Spence AM, O'Sullivan F, Mankoff DA, Wells JM, Grierson JR, Link JM, Krohn KA. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas. J Nucl Med. 2006;47(10):1612-21.
  26. Namdar M, Koepfli P, Grathwohl R, Siegrist PT, Klainguti M, Schepis T, Delaloye R, Wyss CA, Fleischmann SP, Gaemperli O, Kaufmann PA. Caffeine decreases exercise-induced myocardial flow reserve. J Am Coll Cardiol. 2006;47(2):405-10.
  27. Rice O, Saintvictor S, Michaelides M, Thanos P, Gatley SJ. MicroPET investigation of chronic long-term neurotoxicity from heavy ion irradiation. AAPS J 2006; 8:E508-514.
  28. Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F, Tetsuya S, Houle S, Kapur S. An automated method for the extraction of regional data from PET images. Psychiatry Res. 2006;147(1):79-89.
  29. Schiffer WK, Volkow ND, Fowler JS, Alexoff DL, Logan J, Dewey SL. Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine. Synapse. 2006;59(4):243-51.
  30. Schiffer WK, Mirrione MM, Biegon A, Alexoff DL, Patel V, Dewey SL. Serial microPET measures of the metabolic reaction to a microdialysis probe implant. J Neurosci Methods. 2006;155(2):272-84.
  31. Schmidt K, Hoffend J, Altmann A, Strauss LG, Dimitrakopoulou-Strauss A, Engelhardt B, Koczan D, Peter J, Dengler TJ, Mier W, Eisenhut M, Haberkorn U, Kinscherf R. Angiostatin Overexpression in Morris Hepatoma Results in Decreased Tumor Growth but Increased Perfusion and Vascularization. J Nucl Med. 2006;47(3):543-551.
  32. Schmidt K, Hoffend J, Altmann A, Kiessling F, Strauss L, Koczan D, Mier W, Eisenhut M, Kinscherf R, Haberkorn U. Troponin I overexpression inhibits tumor growth, perfusion, and vascularization of morris hepatoma. J Nucl Med. 2006;47(9):1506-14.
  33. Siegrist PT, Gaemperli O, Koepfli P, Schepis T, Namdar M, Valenta I, Aiello F, Fleischmann S, Alkadhi H, Kaufmann PA. Repeatability of cold pressor test-induced flow increase assessed with H(2)(15)O and PET. J Nucl Med. 2006;47(9):1420-6.
  34. Spaeth N, Wyss MT, Pahnke J, Biollaz G, Lutz A, Goepfert K, Westera G, Treyer V, Weber B, Buck A. Uptake of (18)F-fluorocholine, (18)F-fluoro-ethyl-L: -tyrosine and (18)F-fluoro-2-deoxyglucose in F98 gliomas in the rat. Eur J Nucl Med Mol Imaging. 2006;33(6):673-82.
  35. Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Ichise M, Innis RB, Pike VW. PET Imaging of Brain 5-HT1A Receptors in Rat In Vivo with 18F-FCWAY and Improvement by Successful Inhibition of Radioligand Defluorination with Miconazole. J Nucl Med. 2006;47(2):345-353.
  36. Treyer V, Buck A, Schnider A. Effects of baseline task position on apparent activation in functional imaging of memory. Neuropsychologia. 2006;44(3):462-8.
  37. Van Laere K, Casteels C, De Ceuninck L, Vanbilloen B, Maes A, Mortelmans L, Vandenberghe W, Verbruggen A, Dom R. Dual-Tracer Dopamine Transporter and Perfusion SPECT in Differential Diagnosis of Parkinsonism Using Template-Based Discriminant Analysis. J Nucl Med. 2006;47(3):384-392.
  38. Van Laere K, Nuttin B, Gabriels L, Dupont P, Rasmussen S, Greenberg BD, Cosyns P. Metabolic Imaging of Anterior Capsular Stimulation in Refractory Obsessive-Compulsive Disorder: A Key Role for the Subgenual Anterior Cingulate and Ventral Striatum. J Nucl Med. 2006;47(5):740-747.
  39. von Borczyskowski D, Wilke F, Martin B, Brenner W, Clausen M, Mester J, Buchert R. Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET. Nucl Med Commun. 2006;27(9):739-43.
  40. Wagenknecht G, Belitz H, Wolff R, Castellanos J. Segmentation of ROIs/VOIs from small animal images for functional analysis. Nuclear Instruments and Methods in Physics Research A 569. 2006; 481-487.
  41. Willeit M, Ginovart N, Kapur S, Houle S, Hussey D, Seeman P, Wilson AA. High-Affinity States of Human Brain Dopamine D2/3 Receptors Imaged by the Agonist [(11)C]-(+)-PHNO. Biol Psychiatry. 2006;59(5):389-94.
  42. Zoghbi SS, Shetty HU, Ichise M, Fujita M, Imaizumi M, Liow JS, Shah J, Musachio JL, Pike VW, Innis RB. PET Imaging of the Dopamine Transporter with 18F-FECNT: A Polar Radiometabolite Confounds Brain Radioligand Measurements. J Nucl Med. 2006;47(3):520-7.
2005
  1. Beer AJ, Haubner R, Goebel M, Luderschmidt S, Spilker ME, Wester HJ, Weber WA, Schwaiger M. Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients. J Nucl Med. 2005;46(8):1333-41.
  2. Benveniste H, Fowler JS, Rooney W, Ding Y-S, Baumann AL, Moller DH, Du C, Backus W, Logan J, Carter P, Coplan JD, Biegon A, Rosenblum L, Scharf B, Gatley JS, Volkow ND. (2005) Maternal and Fetal 11C-Cocaine Uptake and Kinetics Measured In Vivo by Combined PET and MRI in Pregnant Nonhuman Primates. J Nucl Med 46:312-320.
  3. Boecker H, Sprenger T, Henriksen G, Toelle TR, Spilker ME. Optimal Duration of PET Studies with 18F-Fluoroethyl-Diprenorphine. J Nucl Med. 2005;46(12):2092-6.
  4. Boumezbeur F, Besret L, Valette J, Gregoire MC, Delzescaux T, Maroy R, Vaufrey F, Gervais P, Hantraye P, Bloch G, Lebon V. Glycolysis versus TCA cycle in the primate brain as measured by combining 18F-FDG PET and 13C-NMR. J Cereb Blood Flow Metab. 2005;25(11):1418-23.
  5. Ciernik IF, Huser M, Burger C, Davis JB, Szekely G. Automated functional image-guided radiation treatment planning for rectal cancer. Int J Radiat Oncol Biol Phys. 2005;62(3):893-900.
  6. Finnema SJ, Seneca N, Farde L, Shchukin E, Sovago J, Gulyas B, Wikstrom HV, Innis RB, Neumeyer JL, Halldin C. A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey. Nucl Med Biol. 2005;32(4):353-60.
  7. Fujita M, Zoghbi SS, Crescenzo MS, Hong J, Musachio JL, Lu J-Q, Liow J-S, Seneca N, Tipre DN, Cropley VL. Quantification of brain phosphodiesterase 4 in rat with (R)-[11C]Rolipram-PET. NeuroImage. 2005;26(4):1201-1210.
  8. Gallezot J-D, Bottlaender M, Gregoire M-C, Roumenov D, Deverre J-R, Coulon C, Ottaviani M, Dolle F, Syrota A, Valette H. (2005) In Vivo Imaging of Human Cerebral Nicotinic Acetylcholine Receptors with 2-18F-Fluoro-A-85380 and PET. J Nucl Med 46:240-247.
  9. Ginovart N, Meyer JH, Boovariwala A, Hussey D, Rabiner EA, Houle S, Wilson AA. Positron emission tomography quantification of [(11)C]-harmine binding to monoamine oxidase-A in the human brain. J Cereb Blood Flow Metab. 2005.
  10. Henze M, Dimitrakopoulou-Strauss A, Milker-Zabel S, Schuhmacher J, Strauss LG, Doll J, Macke HR, Eisenhut M, Debus J, Haberkorn U. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-Octreotide Kinetics in Patients with Meningiomas. J Nucl Med. 2005;46(5):763-9.
  11. Herzog H, Tellmann L, Fulton R, Stangier I, Kops ER, Bente K, Boy C, Hurlemann R, Pietrzyk U. Motion Artifact Reduction on Parametric PET Images of Neuroreceptor Binding. J Nucl Med. 2005;46(6):1059-65.
  12. Jacobs AH, Thomas A, Kracht LW, Li H, Dittmar C, Garlip G, Galldiks N, Klein JC, Sobesky J, Hilker R, Vollmar S, Herholz K, Wienhard K, Heiss WD. 18F-Fluoro-L-Thymidine and 11C-Methylmethionine as Markers of Increased Transport and Proliferation in Brain Tumors. J Nucl Med. 2005;46(12):1948-58.
  13. Kaufmann PA, Namdar M, Matthew F, Roffi M, Aschkenasy SV, van der Loo B, Sutsch G, Luscher TF, Jenni R. Novel doppler assessment of intracoronary volumetric flow reserve: validation against PET in patients with or without flow-dependent vasodilation. J Nucl Med. 2005;46(8):1272-7.
  14. Meyer PT, Elmenhorst D, Zilles K, Bauer A. (2005) Simplified quantification of cerebral A(1) adenosine receptors using [(18)F]CPFPX and PET: Analyses based on venous blood sampling. Synapse 55:212-223.
  15. Muzi M, Vesselle H, Grierson JR, Mankoff DA, Schmidt RA, Peterson L, Wells JM, Krohn KA. (2005) Kinetic Analysis of 3'-Deoxy-3'-Fluorothymidine PET Studies: Validation Studies in Patients with Lung Cancer. J Nucl Med 46:274-282.
  16. Muzi M, Mankoff DA, Grierson JR, Wells JM, Vesselle H, Krohn KA. (2005) Kinetic Modeling of 3'-Deoxy-3'-Fluorothymidine in Somatic Tumors: Mathematical Studies. J Nucl Med 46:371-380.
  17. Praschak-Rieder N, Wilson AA, Hussey D, Carella A, Wei C, Ginovart N, Schwarz MJ, Zach J, Houle S, Meyer JH. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry. 2005;58(10):825-30.
  18. Ryzhikov NN, Seneca N, Krasikova RN, Gomzina NA, Shchukin E, Fedorova OS, Vassiliev DA, Gulyas B, Hall H, Savic I, Halldin C. (2005) Preparation of highly specific radioactivity [(18)F]flumazenil and its evaluation in cynomolgus monkey by positron emission tomography. Nucl Med Biol 32:109-116.
  19. Schiffer WK, Alexoff DL, Shea C, Logan J, Dewey SL. Development of a simultaneous PET/microdialysis method to identify the optimal dose of (11)C-raclopride for small animal imaging. J Neurosci Methods. 2005;144(1):25-34.
  20. Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, von Schulthess GK, Hany TF. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology. 2005;235(2):623-8.
  21. Schnider A, Treyer V, Buck A. (2005) The human orbitofrontal cortex monitors outcomes even when no reward is at stake. Neuropsychologia 43:316-323.
  22. Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, Schirrmacher R, Rosch F, Schreckenberger M, Wong DF, Cumming P, Grunder G, Bartenstein P. Parametric mapping of binding in human brain of d2 receptor ligands of different affinities. J Nucl Med. 2005;46(6):964-72.
  23. Steinert HC, Dellea MM, Burger C, Stahel R. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging. Lung Cancer. 2005;49 Suppl 1:S33-5.
  24. Tipre DN, Goldstein DS. Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure. J Nucl Med. 2005;46(11):1775-81.
  25. Vogel R, Indermuhle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C. (2005) The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 45:754-762.
2004
  1. Berding G, Muller-Vahl K, Schneider U, Gielow P, Fitschen J, Stuhrmann M, Harke H, Buchert R, Donnerstag F, Hofmann M, Knoop BO, Brooks DJ, Emrich HM, Knapp WH. (2004) [(123)I]AM281 single-photon emission computed tomography imaging of central cannabinoid CB(1) receptors before and after Delta(9)-tetrahydrocannabinol therapy and whole-body scanning for assessment of radiation dose in tourette patients. Biol Psychiatry 55:904-915
  2. Brenner W, Vernon C, Muzi M, Mankoff DA, Link JM, Conrad EU, Eary JF. (2004) Comparison of different quantitative approaches to 18F-fluoride PET scans. J Nucl Med 45:1493-1500
  3. Fujita M, Varrone A, Kim KM, Watabe H, Zoghbi SS, Seneca N, Tipre D, Seibyl JP, Innis RB, Iida H. (2004) Effect of scatter correction on the compartmental measurement of striatal and extrastriatal dopamine D2 receptors using [123I]epidepride SPET. Eur J Nucl Med Mol Imaging 31:644-654
  4. Ihara M, Tomimoto H, Ishizu K, Mukai T, Yoshida H, Sawamoto N, Inoue M, Doi T, Hashikawa K, Konishi J, Shibasaki H, Fukuyama H. (2004) Decrease in cortical benzodiazepine receptors in symptomatic patients with leukoaraiosis: a positron emission tomography study. Stroke 35:942-947
  5. Itier V, Schonbachler R, Tribollet E, Honer M, Prinz K, Marguerat A, Bertrand S, Bunnelle WH, Schubiger PA, Meyer MD, Sullivan JP, Bertrand D, Westera G. (2004) A-186253, a specific antagonist of the alpha 4 beta 2 nAChRs: its properties and potential to study brain nicotinic acetylcholine receptors. Neuropharmacology 47:538-557
  6. Koepfli P, Wyss CA, Namdar M, Fretz G, Seebauer M, Schirlo C, Kaufmann PA. (2004) Impact of altitude exposure on myocardial blood flow and flow reserve. International Congress Series 1264:111-116
  7. Koepfli P, Wyss CA, Namdar M, Klainguti M, von Schulthess GK, Luscher TF, Kaufmann PA. (2004) {beta}-Adrenergic Blockade and Myocardial Perfusion in Coronary Artery Disease: Differential Effects in Stenotic Versus Remote Myocardial Segments. J Nucl Med 45:1626-1631
  8. Liptrot M, Adams KH, Martiny L, Pinborg LH, Lonsdale MN, Olsen NV, Holm S, Svarer C, Knudsen GM. (2004) Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling. NeuroImage 21:483-493
  9. Meyer PT, Bier D, Holschbach MH, Boy C, Olsson RA, Coenen HH, Zilles K, Bauer A. (2004) Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET. J Cereb Blood Flow Metab 24:323-333
  10. Nowak B, Stellbrink C, Sinha AM, Kaiser H-J, Reinartz P, Koos R, Markus K, Hanrath P, Buell U, Schaefer WM. (2004) Effects of cardiac resynchronization therapy on myocardial blood flow measured by oxygen-15 water positron emission tomography in idiopathic-dilated cardiomyopathy and left bundle branch block. The American Journal of Cardiology 93:496-499
  11. Spilker ME, Sprenger T, Valet M, Henriksen G, Wagner K, Wester H-J, Toelle TR, Boecker H. (2004) Quantification of [18F]diprenorphine kinetics in the human brain with compartmental and non-compartmental modeling approaches. NeuroImage 22:1523-1533
  12. Tipre DN, Fujita M, Chin FT, Seneca N, Vines D, Liow JS, Pike VW, Innis RB. (2004) Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates. Nucl Med Commun 25:737-742
  13. Tipre DN, Lu JQ, Fujita M, Ichise M, Vines D, Innis RB. (2004) Radiation dosimetry estimates for the PET serotonin transporter probe 11C-DASB determined from whole-body imaging in non-human primates. Nucl Med Commun 25:81-86
  14. Weber B, Westera G, Treyer V, Burger C, Khan N, Buck A. (2004) Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status. J Nucl Med 45:1344-1350
  15. Weber B, Burger C, Wyss MT, von Schulthess GK, Scheffold F, Buck A. (2004) Optical imaging of the spatiotemporal dynamics of cerebral blood flow and oxidative metabolism in the rat barrel cortex. Eur J Neurosci 20:2664-2670
2003
  1. Bauer A, Holschbach MH, Meyer PT, Boy C, Herzog H, Olsson RA, Coenen HH, Zilles K. (2003) In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography. NeuroImage 19:1760-1769
  2. Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M. (2003) Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET. J Nucl Med 44:375-384
  3. Buchert R, Wilke F, van den Hoff J, Mester J. (2003) Improved statistical power of the multilinear reference tissue approach to the quantification of neuroreceptor ligand binding by regularization. J Cereb Blood Flow Metab 23:612-620
  4. Ciernik IF, Dizendorf E, Baumert BG, Reiner B, Burger C, Davis JB, Lutolf UM, Steinert HC, Von Schulthess GK. (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. International Journal of Radiation Oncology*Biology*Physics 57:853-863
  5. de Quervain DJ, Henke K, Aerni A, Treyer V, McGaugh JL, Berthold T, Nitsch RM, Buck A, Roozendaal B, Hock C. (2003) Glucocorticoid-induced impairment of declarative memory retrieval is associated with reduced blood flow in the medial temporal lobe. Eur J Neurosci 17:1296-1302
  6. Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C. (2003) Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 44:732-738
  7. Fujita M, Al-Tikriti MS, Tamagnan G, Zoghbi SS, Bozkurt A, Baldwin RM, Innis RB. (2003) Influence of acetylcholine levels on the binding of a SPECT nicotinic acetylcholine receptor ligand [123I]5-I-A-85380. Synapse 48:116-122
  8. Fujita M, Ichise M, van Dyck CH, Zoghbi SS, Tamagnan G, Mukhin AG, Bozkurt A, Seneca N, Tipre D, DeNucci CC, Iida H, Vaupel DB, Horti AG, Koren AO, Kimes AS, London ED, Seibyl JP, Baldwin RM, Innis RB. (2003) Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET. Eur J Nucl Med Mol Imaging 30:1620-1629
  9. Goerres GW, Burger C, Kamel E, Seifert B, Kaim AH, Buck A, Buehler TC, Von Schulthess GK. (2003) Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 226:906-910
  10. Goerres GW, Burger C, Schwitter MR, Heidelberg TN, Seifert B, von Schulthess GK. (2003) PET/CT of the abdomen: optimizing the patient breathing pattern. Eur Radiol 13:734-739
  11. Goerres GW, Ziegler SI, Burger C, Berthold T, Von Schulthess GK, Buck A. (2003) Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 226:577-584
  12. Henke K, Mondadori CRA, Treyer V, Nitsch RM, Buck A, Hock C. (2003) Nonconscious formation and reactivation of semantic associations by way of the medial temporal lobe. Neuropsychologia 41:863-876
  13. Henke K, Treyer V, Weber B, Nitsch RM, Hock C, Wieser HG, Buck A. (2003) Functional neuroimaging predicts individual memory outcome after amygdalohippocampectomy. Neuroreport 14:1197-1202
  14. Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE. (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096-1112
  15. Kamel EM, Burger C, Buck A, von Schulthess GK, Goerres GW. (2003) Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol 13:724-728
  16. Quick HH, Kuehl H, Kaiser G, Aker S, Bosk S, Debatin JF, Ladd ME. Interventional MR Angiography with a Floating Table. Radiology. 2003;229(2):598-602
  17. Strauss LG, Dimitrakopoulou-Strauss A, Haberkorn U. (2003) Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics. J Nucl Med 44:1933-1939
  18. Thireou T, Strauss LG, Dimitrakopoulou-Strauss A, Kontaxakis G, Pavlopoulos S, Santos A. (2003) Performance evaluation of principal component analysis in dynamic FDG-PET studies of recurrent colorectal cancer. Computerized Medical Imaging and Graphics 27:43-51
  19. Treyer V, Jobin M, Burger C, Teneggi V, Buck A. (2003) Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate. Eur J Nucl Med Mol Imaging 30:572-580
  20. Weber B, Spath N, Wyss M, Wild D, Burger C, Stanley R, Buck A. (2003) Quantitative cerebral blood flow measurements in the rat using a beta-probe and H2 15O. J Cereb Blood Flow Metab 23:1455-1460
  21. Wyss CA, Koepfli P, Fretz G, Seebauer M, Schirlo C, Kaufmann PA. (2003) Influence of altitude exposure on coronary flow reserve. Circulation 108:1202-1207
  22. Zimmermann K, Grunberg J, Honer M, Ametamey S, August Schubiger P, Novak-Hofer I. (2003) Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging. Nuclear Medicine and Biology 30:417-427
2002
  1. Ametamey SM, Bruehlmeier M, Kneifel S, Kokic M, Honer M, Arigoni M, Buck A, Burger C, Samnick S, Quack G, Schubiger PA. (2002) PET studies of 18F-memantine in healthy volunteers. Nuclear Medicine and Biology 29:227-231
  2. Burger C, Goerres G, Schoenes S, Buck A, Lonn AH, Von Schulthess GK. (2002) PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging 29:922-927
  3. Carroll TJ, Teneggi V, Jobin M, Squassante L, Treyer V, Hany TF, Burger C, Wang L, Bye A, Von Schulthess GK, Buck A. (2002) Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab 22:1149-1156
  4. Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, Wu H, Burger C, Bernd L, Ewerbeck V. (2002) The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med 43:510-518
  5. Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schulthess GK. (2002) PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 29:351-360
  6. Goerres GW, Kamel E, Seifert B, Burger C, Buck A, Hany TF, Von Schulthess GK. (2002) Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 43:1469-1475
  7. Ichise M, Toyama H, Innis RB, Carson RE. (2002) Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 22:1271-1281
  8. Kamel E, Hany TF, Burger C, Treyer V, Lonn AH, von Schulthess GK, Buck A. (2002) CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging 29:346-350
  9. Kamel EM, Goerres GW, Burger C, von Schulthess GK, Steinert HC. (2002) Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET-CT image fusion -- report of six cases. Radiology 224:153-156
  10. Schonbachler RD, Gucker PM, Arigoni M, Kneifel S, Vollenweider FX, Buck A, Burger C, Berthold T, Bruhlmeier M, Schubiger PA, Ametamey SM. (2002) PET imaging of dopamine transporters in the human brain using [11C]-[beta]-CPPIT, a cocaine derivative lacking the 2[beta]-ester function. Nuclear Medicine and Biology 29:19-27
  11. Tauscher J, Kapur S, Verhoeff NP, Hussey DF, Daskalakis ZJ, Tauscher-Wisniewski S, Wilson AA, Houle S, Kasper S, Zipursky RB. (2002) Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635. Arch Gen Psychiatry 59:514-520
  12. Verhoeff NP, Hussey D, Lee M, Tauscher J, Papatheodorou G, Wilson AA, Houle S, Kapur S. (2002) Dopamine depletion results in increased neostriatal D(2), but not D(1), receptor binding in humans. Mol Psychiatry 7:233, 322-238
  13. Weber B, Burger C, Biro P, Buck A. (2002) A femoral arteriovenous shunt facilitates arterial whole blood sampling in animals. Eur J Nucl Med Mol Imaging 29:319-323
  14. Weber B, Fouad K, Burger C, Buck A. (2002) White matter glucose metabolism during intracortical electrostimulation: a quantitative [(18)F]Fluorodeoxyglucose autoradiography study in the rat. Neuroimage 16:993-998
2001
  1. Dimitrakopoulou-Strauss A, Strauss LG, Burger C. (2001) Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. J Nucl Med 42:248-256
  2. Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, Burger C, Heichel T, Willeke F, Mechtersheimer G, Lehnert T. (2001) Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading. J Nucl Med 42:713-720
  3. Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S. (2001) Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies. J Cereb Blood Flow Metab 21:1342-1353
  4. Ichise M, Meyer JH, Yonekura Y. (2001) An introduction to PET and SPECT neuroreceptor quantification models. J Nucl Med 42:755-763
  5. Kaim AH, Burger C, Ganter CC, Goerres GW, Kamel E, Weishaupt D, Dizendorf E, Schaffner A, von Schulthess GK. (2001) PET-CT-guided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report. Radiology 221:818-821
  6. Kaufmann PA, Schirlo C, Pavlicek V, Berthold T, Burger C, von Schulthess GK, Koller EA, Buck A. (2001) Increased myocardial blood flow during acute exposure to simulated altitudes. J Nucl Cardiol 8:158-164
  7. Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, Houle S. (2001) Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 158:1843-1849
  8. Patt JT, Spang JE, Buck A, Cristina H, Arras M, Schubiger PA, Westera G. (2001) Synthesis and in vivo studies of the stereoisomers of N-[11C]methyl-homoepibatidine. Nuclear Medicine and Biology 28:645-655
  9. Wu H, Dimitrakopoulou-Strauss A, Heichel TO, Lehner B, Bernd L, Ewerbeck V, Burger C, Strauss LG. (2001) Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUV in comparison to Patlak analysis. Eur J Nucl Med 28:704-710
2000
  1. Arigoni M, Kneifel S, Fandino J, Khan N, Burger C, Buck A. (2000) Simplified quantitative determination of cerebral perfusion reserve with H2(15)O PET and acetazolamide. Eur J Nucl Med 27:1557-1563
  2. Buck A, Gucker PM, Schonbachler RD, Arigoni M, Kneifel S, Vollenweider FX, Ametamey SM, Burger C. (2000) Evaluation of serotonergic transporters using PET and [11C](+)McN-5652: assessment of methods. J Cereb Blood Flow Metab 20:253-262
  3. Fujita M, Tamagnan G, Zoghbi SS, Al-Tikriti MS, Baldwin RM, Seibyl JP, Innis RB. (2000) Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT. J Nucl Med 41:1552-1560
  4. Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, Hinz U, Strauss LG, Zhang YM, Mechtersheimer G, Attigah N, Lehnert T, Herfarth C. (2000) Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 231:380-386
1999
  1. Fujita M, Seibyl JP, Verhoeff NP, Ichise M, Baldwin RM, Zoghbi SS, Burger C, Staley JK, Rajeevan N, Charney DS, Innis RB. (1999) Kinetic and equilibrium analyses of [(123)I]epidepride binding to striatal and extrastriatal dopamine D(2) receptors. Synapse 34:290-304
1998
  1. Bicik I, Radanov BP, Schafer N, Dvorak J, Blum B, Weber B, Burger C, von Schulthess GK, Buck A. (1998) PET with 18fluorodeoxyglucose and hexamethylpropylene amine oxime SPECT in late whiplash syndrome. Neurology 51:345-350
  2. Buck A, Schirlo C, Jasinksy V, Weber B, Burger C, von Schulthess GK, Koller EA, Pavlicek V. (1998) Changes of cerebral blood flow during short-term exposure to normobaric hypoxia. J Cereb Blood Flow Metab 18:906-910
  3. Mikolajczyk K, Szabatin M, Rudnicki P, Grodzki M, Burger C. (1998) A JAVA environment for medical image data analysis: initial application for brain PET quantitation. Med Inform (Lond) 23:207-214
1997
  1. Burger C, Buck A. (1997) Requirements and implementation of a flexible kinetic modeling tool. J Nucl Med 38:1818-1823
[ Dear user, please inform us if you would like to add additional "PMOD" publications to this list ]
Home News Contact Us Distribution
(c) 2009 PMOD Technologies Ltd